https://blog.lifesciencenation.com/2026/03/31/the-problem-is-not-the-science-a-seven-part-series-on-de-risking-signal-and-investability/2026-03-31T16:14:24+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/31/best-practices-for-cap-table-management-what-founders-need-to-know-before-their-next-raise/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/cap-table-april-14.jpgcap-table-april-142026-03-31T13:24:54+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/31/resi-europe-2026-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/resi-sd-26-banner.jpgRESI-SD-26-Banner2026-03-31T13:15:50+00:00monthlyhttps://blog.lifesciencenation.com/previous-issues/2026-03-31T12:02:57+00:00weekly0.6https://blog.lifesciencenation.com/2026/03/17/resi-europe-2026-program-guide-released/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/img_2812.jpegScreenshotScreenshot2026-03-17T12:48:26+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/hot-investor-mandate-life-sciences-advisory-vc-firm-seeks-life-sciences-companies-targeting-oncology-cns-infectious-diseases-and-more/2026-03-10T16:15:41+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/hot-investor-mandate-family-office-backed-investment-vehicle-seeks-innovative-medtech-opportunities-in-us-western-europe-and-asia/2026-03-10T16:15:15+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/hot-investor-mandate-investment-arm-of-large-healthcare-enterprise-invests-and-partners-with-innovations-with-china-and-global-market-potential/2026-03-10T16:14:41+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/hot-investor-mandate-asia-based-investment-manager-invests-in-healthcare-and-life-sciences-focused-funds-and-companies-across-the-globe/2026-03-10T16:14:15+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/resi-san-diego-2026-investor-panel-lineup-announced/2026-03-10T16:13:03+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/resi-europe-2026-ipc-finalists/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/resi-europe-2026-ipc-finalists.jpgRESI-Europe-2026-IPC-Finalists2026-03-10T15:04:44+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/fundraising-bootcamp-ahead-of-resi-europe-2026-preparing-founders-for-investor-engagement/2026-03-10T15:04:42+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/10/the-trap-of-complacency/2026-03-10T15:04:34+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/hot-investor-mandate-family-office-backed-firm-seeks-to-invest-in-therapeutics-especially-rare-diseases-and-areas-of-unmet-medical-need/2026-03-03T17:49:58+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/hot-investor-mandate-global-biopharmaceutical-seeks-strategic-investment-and-partnering-opportunities-with-early-stage-therapeutics-assets/2026-03-03T17:49:32+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/hot-investor-mandate-family-office-invests-in-pre-clinical-and-clinical-stage-biotech-and-tech-enabled-healthcare-technologies-in-north-america/2026-03-03T17:48:58+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/hot-investor-mandate-cross-border-vc-firm-with-new-early-stage-fund-invests-in-biotech-medtech-and-enabling-platforms-in-north-america-and-asia/2026-03-03T17:48:30+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/resi-europe-2026-investor-panels-take-the-stage-in-lisbon/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/resi-europe-2026-investor-panel-agenda.pngRESI-Europe-2026-Investor-Panel-Agenda2026-03-03T16:23:42+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/eu-webinar-series-from-discovery-to-decision-making-early-stage-life-science-legible-to-capital/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/session-3-banner.jpgSession 3 banner2026-03-03T15:30:55+00:00monthlyhttps://blog.lifesciencenation.com/2026/03/03/novotech-at-resi-jpm-strategic-early-clinical-development-for-biotech-sponsors/https://blog.lifesciencenation.com/wp-content/uploads/2026/03/marina-mullins-headshot.jpgMarina Mullins Headshot2026-03-03T14:41:22+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/hot-investor-mandate-vc-firm-invests-up-to-5m-in-medical-device-companies-based-in-north-america-with-a-preference-for-510k-cardio-and-single-use-devices/2026-02-24T17:14:10+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/hot-investor-mandate-usa-based-vc-firm-seeks-life-science-tools-technologies-based-in-north-america-and-europe/2026-02-24T17:12:19+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/hot-investor-mandate-asia-based-private-investment-firm-actively-looks-for-cross-border-deals-in-all-life-science-and-healthcare-sectors/2026-02-24T17:11:56+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/hot-investor-mandate-strategic-corporate-vc-focused-on-early-stage-therapeutics-medical-devices-and-digital-health-across-the-globe/2026-02-24T17:11:37+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/resi-europe-partnering-opens-march-2-secure-investor-meetings-early-and-bring-a-complimentary-second-attendee/2026-02-24T14:42:06+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/resi-europe-and-european-vc-coalition-seek-to-boost-eu-biotech-investment/2026-02-24T14:42:04+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/webinar-to-fundraising-strategy-preparing-ceos-for-resi-europe-and-beyond/2026-02-24T14:42:02+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/24/the-needle-issue-24/2026-02-24T14:07:36+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/hot-investor-mandate-large-holding-company-manages-both-early-and-late-stage-focused-funds-investing-up-to-10-15m-in-novel-therapeutics/2026-02-18T17:34:03+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/hot-investor-mandate-corporate-vc-seeks-early-stage-oncology-therapeutics-platform-technologies-in-us-and-europe/2026-02-18T17:33:57+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/hot-investor-mandate-early-stage-venture-fund-seeks-data-driven-diagnostics-and-digital-health/2026-02-18T17:33:51+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/hot-investor-mandate-pre-seed-and-seed-stage-vc-firm-backing-ai-and-next-generation-computing-in-healthcare/2026-02-18T17:33:45+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/06/what-are-best-practices-for-cap-table-management-investors-banks-weigh-in/2026-02-18T16:21:16+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/confirmed-investors-attending-resi-europe-2026-early-bird-rates-end-friday/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/ci-02142026.jpgCI-021420262026-02-18T16:20:20+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/18/resi-ipc-winner-verimmune-advances-a-new-immuno-oncology-playbook/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/jw.jpgJW2026-02-18T16:19:38+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/new-eu-webinar-series-from-discovery-to-decision-making-early-stage-life-science-legible-to-capital/2026-02-13T15:45:27+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/hot-investor-mandate-biotech-and-healthcare-focused-incubator-and-investment-firm-invests-from-seed-to-pre-ipo-rounds-across-the-globe/2026-02-10T17:24:08+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/hot-investor-mandate-seed-fund-focuses-on-early-stage-breakthrough-technologies-addressing-longevity-and-healthspan/2026-02-10T17:24:03+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/hot-investor-mandate-asia-based-vc-firm-engages-in-cross-border-investments-across-life-sciences-and-tech-driven-healthcare-companies/2026-02-10T17:23:57+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/hot-investor-mandate-europe-based-vc-invests-in-pre-seed-and-seed-stage-companies-in-the-intersection-of-deeptech-and-life-sciences/2026-02-10T17:23:50+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/investor-fireside-chat-in-barcelona-building-momentum-toward-resi-europe/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/brenda.jpgBrenda2026-02-10T17:13:09+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/life-science-nation-names-dealflow-eu-as-a-title-sponsor-of-resi-europe-lisbon-highlights-eic-participation-pathway/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/resi-europe-2026-1500.jpgRESI-Europe-2026-1500https://blog.lifesciencenation.com/wp-content/uploads/2026/02/dealflow-eu.jpgDealflow-eu2026-02-10T16:53:19+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/europe-doesnt-have-a-capital-problem-it-has-a-translation-problem/2026-02-10T13:54:16+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/10/the-needle-issue-23/2026-02-10T13:25:30+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/hot-investor-mandate-multi-stage-investment-firm-seeks-early-and-growth-stage-companies-across-all-life-science-and-healthcare-sectors/2026-02-03T15:38:09+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/hot-investor-mandate-vc-firm-invests-in-seed-stage-life-science-companies-in-north-america-and-europe-addressing-age-related-diseases/2026-02-03T15:38:04+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/hot-investor-mandate-newly-established-corporate-venture-initiative-strategically-invests-in-life-sciences-and-ai-powered-healthcare-technologies/2026-02-03T15:37:58+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/hot-investor-mandate-usa-based-vc-firm-actively-invests-in-seed-to-series-a-ai-and-computational-driven-techbio-companies/2026-02-03T15:37:50+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/hear-from-a-resi-jpm-2026-title-sponsor-biometas/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/simon-hua.jpgSimon-Huahttps://blog.lifesciencenation.com/wp-content/uploads/2026/02/resi-logo-new-250.pngRESI-LOGO--NEW--250https://blog.lifesciencenation.com/wp-content/uploads/2026/02/1770001148494.jpg1770001148494https://blog.lifesciencenation.com/wp-content/uploads/2026/02/1770001131432.jpg1770001131432https://blog.lifesciencenation.com/wp-content/uploads/2026/02/1770001066424.jpg17700010664242026-02-03T15:06:16+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/why-early-stage-companies-need-the-right-partnering-room/2026-02-03T13:46:03+00:00monthlyhttps://blog.lifesciencenation.com/2026/02/03/advancing-womens-health-diagnostics-through-glycoproteomics-proseek-bio-at-the-innovators-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2026/02/michelle-hill.jpgMichelle Hill2026-02-03T13:44:19+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/proseek-bio-claims-global-bronze-in-san-francisco-strengthening-brisbanes-medtech-credentials/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/fy26-global-accelertor-cohort-jpm2026.jpgFY26 Global Accelertor Cohort - JPM2026https://blog.lifesciencenation.com/wp-content/uploads/2026/01/proseek-bio-bronze.jpgProseek Bio Bronze2026-01-27T20:20:21+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/hot-investor-mandate-corporate-vc-arm-of-global-pharma-strategically-invests-in-pre-clinical-therapeutics-in-areas-including-oncology-cns-immunology/2026-01-27T16:12:23+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/hot-investor-mandate-vc-firm-with-multiple-life-science-focused-funds-seeks-early-stage-therapeutics-and-ai-enabled-technologies/2026-01-27T16:12:16+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/hot-investor-mandate-early-stage-focused-venture-fund-looks-for-neuropsychiatric-opportunities-from-pre-seed-to-series-a-rounds/2026-01-27T16:12:09+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/hot-investor-mandate-multi-billion-aum-vc-firm-invests-up-to-20m-in-innovative-biotech-and-medtech-platforms-and-products/2026-01-27T16:12:03+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/the-reality-of-european-global-partnering/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/resi-europe-2026-email-banner-v2.0.jpgRESI-Europe-2026-Email-Banner-v2.02026-01-27T15:07:19+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/investor-panels-at-resi-europe-2026/2026-01-27T15:06:55+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/resi-jpm-2026-by-the-numbers/2026-01-27T15:06:41+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/innovators-pitch-challenge-spotlight-sania-therapeutics-and-a-controllable-approach-to-gene-therapy/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/paula-cerqueira-vp-of-scientific-strategy.jpgPaula Cerqueira, VP of Scientific Strategy2026-01-27T15:06:22+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/27/the-needle-issue-22/2026-01-27T14:30:18+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/21/winners-announced-at-resi-jpm-2026-innovators-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/resi-jpm-26-judge-picks.jpgRESI-JPM-26-Judge-Picks2026-01-21T15:17:37+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/21/myonerv-resi-london-innovators-pitch-challenge-winner-advancing-stroke-rehabilitation/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/email-banner-resi-eu-26.jpgEmail-Banner-RESI EU 26https://blog.lifesciencenation.com/wp-content/uploads/2026/01/sam-kamali.jpgSam-Kamali2026-01-21T15:14:15+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/21/resi-2026-sponsorship-that-delivers-visibility-connection-and-real-engagement/2026-01-21T15:13:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/navigating-jpm-week-a-guide-to-resis-2026-event-lineup/2026-01-08T19:27:27+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/06/naugen-global-innovation-showcase-at-resi-jpm-2026/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/karis-bio.jpgKaris-Biohttps://blog.lifesciencenation.com/wp-content/uploads/2026/01/nexthera.jpgNexTherahttps://blog.lifesciencenation.com/wp-content/uploads/2026/01/shoealls.jpgShoeallShttps://blog.lifesciencenation.com/wp-content/uploads/2026/01/medicosbiotech.jpgMedicosBiotechhttps://blog.lifesciencenation.com/wp-content/uploads/2026/01/naugen.jpgNaugen2026-01-06T17:54:46+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/06/resi-jpm-innovators-pitch-judges-announced/2026-01-06T17:51:51+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/06/trilliumbio-at-resi-jpm-advancing-biomarker-discovery-into-patient-ready-diagnostics/https://blog.lifesciencenation.com/wp-content/uploads/2026/01/laura.jpgLaura2026-01-06T17:22:38+00:00monthlyhttps://blog.lifesciencenation.com/2026/01/06/the-needle-issue-21/2026-01-06T12:49:08+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/29/resi-jpm-2026-program-guide-released/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/resi-jpm-2026-program-guide_cover.jpgRESI-JPM-2026-Program-Guide_Cover2025-12-30T20:11:39+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/hot-investor-mandate-family-office-firm-actively-seeking-early-stage-life-science-technologies-with-a-focus-on-therapeutics-and-drug-development/2025-12-16T17:46:18+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/hot-investor-mandate-vc-firm-with-us-and-asia-offices-invests-in-early-stage-life-science-companies-in-seed-to-series-a-rounds/2025-12-16T17:46:09+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/hot-investor-mandate-global-pharma-with-investment-subsidiary-seeks-companies-developing-novel-drugs-open-to-various-modalities/2025-12-16T17:46:01+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/hot-investor-mandate-europe-based-vc-firm-with-strong-track-record-invests-up-to-e20m-open-to-all-life-science-healthcare-sectors/2025-12-16T17:45:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/resi-jpm-2026-investor-panels-announced/2025-12-16T17:42:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/companies-to-watch-in-2026/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/qnity.jpgQnityhttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/alterna-therapeutics.jpgAlterna-Therapeuticshttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/qualisure.pngQualisurehttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/hiro.jpgHiROhttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/iqure.pngiQurehttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/cureage.pngCureAgehttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/adaptyx-biosciences-1.jpgAdaptyx-Biosciences-1https://blog.lifesciencenation.com/wp-content/uploads/2025/12/oncovita.jpgOncovitahttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/bilix.jpgBilixhttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/neurohope-therapeutics-inc.jpgNeuroHope-Therapeutics-Inc2025-12-16T17:30:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/16/sunday-space-two-full-days-of-resi-jpm/2025-12-16T17:06:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/09/why-the-world-is-looking-to-brisbane-australia-for-the-future-of-health-innovation/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/medtech-global-accelerator-cohort-4.jpgMedTech-Global-Accelerator-Cohort-4https://blog.lifesciencenation.com/wp-content/uploads/2025/12/713846-brisbane_brisbane-city_queens-wharf_brisbaneriver_day2-2.jpg713846-brisbane_brisbane-city_queens-wharf_brisbaneriver_day2-(2)https://blog.lifesciencenation.com/wp-content/uploads/2025/12/beda.jpgBEDA2025-12-10T14:02:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/09/how-resi-helps-investors-source-breakthrough-technologies-an-interview-with-toru-jay-seo-of-newsight-tech-angels/2025-12-09T16:46:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/09/innovators-pitch-challenge-winners-announced-at-resi-london-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/resi-london-judge-picks.pngRESI London Judge Pickshttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/resi-london-ipc-winners.pngRESI London IPC Winnershttps://blog.lifesciencenation.com/wp-content/uploads/2025/12/resi-2026-banner.jpgRESI-2026-Banner2025-12-09T16:46:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/09/the-needle-issue-20/2025-12-09T13:09:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/you-are-invited-join-kansai-life-science-accelerator-program-klsap-demo-day-at-resi-jpm-2026/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/progenicyte.jpgProgenicyte2025-12-05T15:35:06+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/resi-jpm-2026-ipc-finalists/https://blog.lifesciencenation.com/wp-content/uploads/2025/12/resi-jpm-2026-ipc-finalists.jpgRESI-JPM-2026-IPC-Finalists2025-12-02T14:29:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/hot-investor-mandate-vc-firm-invests-up-to-3m-across-4-pillars-of-medical-devices/2025-12-02T13:34:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/hot-investor-mandate-french-vc-firm-seeks-companies-intersecting-deep-tech-and-life-sciences/2025-12-02T13:34:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/hot-investor-mandate-longevity-focused-vc-firm-invests-500k-1-5m-in-the-u-s-and-europe/2025-12-02T13:34:18+00:00monthlyhttps://blog.lifesciencenation.com/2025/12/02/hot-investor-mandate-us-based-venture-studio-and-accelerator-funds-up-to-5m-to-very-early-stage-traditional-therapeutic-modalities/2025-12-02T13:34:16+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/25/explore-the-resi-london-2025-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2025/11/resi-london-2025-program-guide_cover.jpgRESI-London-2025-Program-Guide_Cover2025-11-25T15:47:38+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/25/resi-2026-series-connecting-life-science-innovators-with-capital-and-partners/https://blog.lifesciencenation.com/wp-content/uploads/2025/11/resi-2026-series.jpgRESI-2026-SERIES2025-11-25T15:47:35+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/25/the-needle-issue-19/2025-11-25T13:11:53+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/hot-investor-mandate-family-office-backed-venture-fund-invests-in-pre-clinical-therapeutic-platforms-across-the-globe/2025-11-18T18:09:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/hot-investor-mandate-vc-firm-invests-in-drug-discovery-enabling-tools-techbio-ai-driven-applications-globally-with-a-focus-on-usa-based-companies/2025-11-18T18:09:26+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/hot-investor-mandate-usa-based-vc-firm-seeks-longevity-focused-investments-engaging-in-seed-to-series-a-rounds/2025-11-18T18:09:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/hot-investor-mandate-late-stage-venture-growth-equity-investor-backing-de-risked-therapeutics-and-medical-device-opportunities/2025-11-18T18:09:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/resi-london-innovators-pitch-challenge-finalists-2/2025-11-18T15:48:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/discover-early-stage-life-science-opportunities-at-london-bio-innovation-week/2025-11-18T15:48:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/18/early-stage-partnerships-with-mosaic-biosciences-at-resi-london/2025-11-18T15:48:01+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/lsn-fundraising-bootcamp-at-london-bio-innovation-week-2026/2025-11-12T19:23:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/hot-investor-mandate-family-office-backed-life-sciences-fund-invests-across-therapeutics-diagnostics-and-digital-health-globally/2025-11-12T17:12:28+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/hot-investor-mandate-evergreen-fund-actively-seeking-therapeutics-and-medical-device-opportunities-investing-up-to-10m-in-the-us-and-beyond/2025-11-12T17:12:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/hot-investor-mandate-europe-based-vc-invests-across-all-life-science-sectors-with-a-focus-on-those-based-in-us-and-europe/2025-11-12T17:12:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/hot-investor-mandate-early-stage-focused-vc-firm-invests-in-pre-seed-to-series-a-healthcare-companies-with-ai-driven-technologies/2025-11-12T17:12:09+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/from-lab-to-market-why-life-science-companies-are-drawn-to-singapore/https://blog.lifesciencenation.com/wp-content/uploads/2025/11/enterprise-singapore.jpgEnterprise-Singapore2025-11-12T15:37:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/make-your-mark-at-resi-jpm-with-the-new-company-presentation-track/2025-11-12T13:43:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/12/the-needle-issue-18/2025-11-12T13:02:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/hot-investor-mandate-western-europe-based-firm-invests-up-to-10m-in-life-sciences-including-drug-discovery-and-enabling-technologies/2025-11-04T17:49:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/hot-investor-mandate-vc-firm-headquartered-in-asia-seeks-early-stage-life-science-companies-in-the-intersection-of-science-and-technology/2025-11-04T17:49:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/hot-investor-mandate-private-investment-firm-invests-in-seed-to-series-a-medical-devices-diagnostics-and-digital-health-companies-in-north-america/2025-11-04T17:48:44+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/hot-investor-mandate-europe-based-vc-firm-invests-in-early-stage-companies-in-tech-enabled-life-science-and-healthcare-companies/2025-11-04T17:48:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/resi-jpm-2026-a-global-hub-for-life-science-connections/https://blog.lifesciencenation.com/wp-content/uploads/2025/11/flags.pngFlagshttps://blog.lifesciencenation.com/wp-content/uploads/2025/11/resi-jpm-2026-cohorth.jpgRESI-JPM-2026-Cohorth2025-11-04T17:03:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/the-real-secret-sauce-for-startup-success/2025-11-04T14:04:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/11/04/beyond-borders-how-to-prepare-for-partnering-success-at-resi-london-in-the-winter/2025-11-04T14:03:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/hot-investor-mandate-venture-fund-seeks-to-invest-in-usa-based-therapeutics-medical-devices-and-diagnostics-across-key-unmet-need-areas/2025-10-28T17:12:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/hot-investor-mandate-angel-syndicate-targets-investments-into-life-science-tools-software-and-platform-technologies-across-pre-seed-to-series-a/2025-10-28T17:11:56+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/hot-investor-mandate-western-europe-based-vc-firm-focuses-on-medtech-and-digital-health-investments-across-the-globe/2025-10-28T17:11:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/hot-investor-mandate-global-investment-firm-seeks-novel-cell-gene-therapies-in-pre-clinical-and-early-clinical-stage-investing-up-to-10m/2025-10-28T17:11:10+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/winning-innovation-isotech-on-blood-pressure-therapy-and-pitching-at-resi/2025-10-28T16:37:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/kobe-biomedical-innovation-cluster-kbic-joins-resi-jpm-2026-as-gold-sponsor/https://blog.lifesciencenation.com/wp-content/uploads/2025/10/c-biomex.jpgC-Biomexhttps://blog.lifesciencenation.com/wp-content/uploads/2025/10/genemedicine.jpgGeneMedicinehttps://blog.lifesciencenation.com/wp-content/uploads/2025/10/ixgene.jpgiXgenehttps://blog.lifesciencenation.com/wp-content/uploads/2025/10/kbic.jpgKbic2025-10-28T16:35:10+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/apexbrasil-and-abiquifi-deepen-strategic-alliance-with-life-science-nation-to-globalize-brazils-life-science-ecosystem-and-leveraging-the-resi-jpm-january-event/https://blog.lifesciencenation.com/wp-content/uploads/2025/10/abiquifi-brazil.jpgAbiquifi-Brazilhttps://blog.lifesciencenation.com/wp-content/uploads/2025/10/apexbrasil.jpgApexBrasil2025-10-28T16:20:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/28/resi-london-2025-an-international-hub-for-connections/https://blog.lifesciencenation.com/wp-content/uploads/2025/10/resi-london-with-flag.jpgRESI-London-with-Flag2025-10-28T16:15:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/hot-investor-mandate-usa-based-vc-firm-invests-up-to-20m-with-strong-focus-on-therapeutics-open-to-medical-devices-and-diagnostics-2/2025-10-21T16:43:58+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/hot-investor-mandate-seed-stage-investment-firm-seeks-europe-based-enabling-platforms-diagnostics-digital-health-and-more/2025-10-21T16:43:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/hot-investor-mandate-vc-firm-invests-e500k-5m-in-life-science-tools-therapeutics-and-medtech-in-us-and-europe/2025-10-21T16:43:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/hot-investor-mandate-usa-based-vc-firm-invests-in-seed-stage-companies-focused-on-cancer-related-digital-solutions/2025-10-21T16:43:36+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/resi-london-2025-dec-4-see-feedback-from-previous-attendees-about-the-uks-biggest-investment-conference/2025-10-21T16:01:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/confirmed-investors-at-resi-london-2025/2025-10-21T16:00:41+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/the-needle-issue-17/2025-10-21T15:57:09+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/21/make-the-most-of-jpm-week-with-sunday-partnering-at-the-marriott-marquis/2025-10-21T15:50:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/hot-investor-mandate-usa-based-vc-firm-invests-up-to-20m-with-strong-focus-on-therapeutics-open-to-medical-devices-and-diagnostics/2025-10-15T16:40:28+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/hot-investor-mandate-strategic-corporate-venture-fund-invests-in-first-in-class-novel-therapies-engaging-in-companies-in-pre-ind-stage/2025-10-15T16:40:26+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/hot-investor-mandate-us-venture-fund-seeks-early-stage-opportunities-across-all-life-sciences-with-strongest-interest-and-expertise-in-medical-devices/2025-10-15T16:40:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/hot-investor-mandate-vc-firm-invests-up-to-e10m-in-central-and-western-europe-based-companies-in-therapeutics-medical-devices-diagnostics/2025-10-15T16:40:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/host-your-jpm-reception-presentation-showcase-or-partnering-at-the-marriott-marquis/2025-10-15T14:12:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/lsn-ecosystem-deal-matrix-1-29-billion-and-counting/2025-10-15T13:44:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/will-pubmed-be-shutdown/2025-10-15T13:44:36+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/15/from-resi-boston-to-global-growth-bilix-on-winning-the-innovators-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2025/10/myung-kim.jpgMyung-Kim2025-10-15T13:43:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/hot-investor-mandate-china-based-investment-firm-backs-early-and-growth-stage-therapeutics-medical-devices-and-diagnostics-companies-in-china-the-u-s-and-canada/2025-10-07T15:25:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/hot-investor-mandate-us-based-vc-invests-in-seed-stage-companies-addressing-age-related-diseases-across-therapeutics-medtech-and-digital-health/2025-10-07T15:25:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/hot-investor-mandate-europe-based-global-pharmaceutical-company-seeks-partnerships-with-early-stage-therapeutics-firms-in-rare-diseases-respiratory-health-and-critical-care/2025-10-07T15:25:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/hot-investor-mandate-north-america-based-family-office-seeking-early-and-late-stage-opportunities-in-life-sciences-with-technology-angle/2025-10-07T15:25:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/investor-panels-at-resi-jpm-2026/2025-10-07T13:31:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/five-leading-life-science-organisations-collaborate-on-inaugural-london-bio-innovation-week/https://blog.lifesciencenation.com/wp-content/uploads/2025/10/9d07e8cd6ade4baea9df3b2bb6a07331_851ce8fa99e2c0cf35c0bdb6b88b3a96.jpg9d07e8cd6ade4baea9df3b2bb6a07331!_!851ce8fa99e2c0cf35c0bdb6b88b3a96https://blog.lifesciencenation.com/wp-content/uploads/2025/10/lbw-banner-for-press-release.pngLBW banner for press releasehttps://blog.lifesciencenation.com/wp-content/uploads/2025/10/tony-jone.jpgTony Jone2025-10-07T13:31:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/how-100-pharma-tariffs-could-ripple-through-early-stage-biotech-investment/2025-10-07T13:30:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/10/07/the-needle-issue-16/2025-10-07T11:51:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/lsn-staff-on-global-event-circuit-find-out-who-what-and-where/2025-09-30T15:21:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/hot-investor-mandate-life-sciences-focused-fund-with-global-reach-invests-in-therapeutics-and-medtech-companies-based-in-north-america-europe-and-parts-of-asia/2025-09-30T15:18:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/hot-investor-mandate-us-based-single-family-office-invests-in-breakthrough-therapeutics-medical-devices-and-diagnostics-in-north-america/2025-09-30T15:18:42+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/hot-investor-mandate-usa-based-early-stage-fund-invests-in-medical-devices-diagnostics-digital-health-companies-in-underserved-regions/2025-09-30T15:18:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/hot-investor-mandate-impact-fund-seeks-early-stage-companies-across-europe-investing-in-all-life-science-and-healthcare-sectors/2025-09-30T15:18:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/super-early-bird-rates-end-october-3-for-resi-london-and-resi-jpm/2025-09-30T14:45:18+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/30/finalist-in-the-resi-boston-innovators-pitch-challenge-meet-m6p-therapeutics/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/cuong-do.pngCuong-Do2025-09-30T14:26:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/23/resi-boston-september-2025-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/resi-boston-judge-selected.jpgRESI-Boston-Judge-Selectedhttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/m6p.jpgM6Phttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/bilix-1.jpgBilixhttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/isotech.jpgIsoTechhttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/m6p-therapeutics.jpgM6P-Therapeuticshttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/isotech-ltd.jpgIsotech-Ltd2025-09-23T19:33:17+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/23/life-science-nation-and-the-ganesha-lab-launch-a-global-two-way-innovation-bridge-connecting-south-america-anchored-in-sao-paulo-brazil-to-the-international-healthcare-arena/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/resi-banner-25-26.pngRESI-Banner-25-26https://blog.lifesciencenation.com/wp-content/uploads/2025/09/resi-email-banner-london-jpm-eu.pngRESI-Email-Banner-(London-JPM-Eu)2025-09-23T13:55:29+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/23/investor-panels-at-resi-london-december-2025/2025-09-23T13:46:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/23/get-fundraising-ready-before-biospain-2025-free-with-your-resi-registration/2025-09-23T13:46:42+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/23/the-needle-issue-15/2025-09-23T12:29:36+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/hot-investor-mandate-china-based-pe-firm-invests-in-various-life-science-sectors-investing-5-50m-from-series-a-through-pre-ipo-in-us-europe-and-china/2025-09-09T16:41:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/hot-investor-mandate-corporate-venture-fund-seeks-in-materials-science-and-nutritional-health-companies-across-the-globe/2025-09-09T16:41:17+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/hot-investor-mandate-europe-based-investment-firm-seeks-therapeutics-and-medical-device-companies-investing-up-to-e20m-over-company-lifecycle/2025-09-09T16:41:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/hot-investor-mandate-global-vc-firm-focuses-on-backing-innovations-in-therapeutics-diagnostics-and-digital-health-addressing-aging-and-longevity/2025-09-09T16:41:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/explore-the-resi-boston-september-2025-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/resibospg25-cover.jpgRESIBOSPG25-Cover2025-09-09T15:08:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/genaxis-silver-sponsor-of-resi-boston-hosts-exclusive-startup-showcase/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/deepsonbio.jpgDeepsonbiohttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/radahaim.jpgRadaHaimhttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/exosystems.jpgEXOSYSTEMShttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/laon-medi.jpgLaon-Medihttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/bilix.jpgBilixhttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/genaxis.jpgGenaxis2025-09-09T15:07:35+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/partnering-for-growth-dla-piper-on-supporting-life-science-innovation-at-resi-boston/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/lauren-murdza.jpgLauren-Murdza2025-09-09T14:58:06+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/freedom-to-operate-what-it-is-and-why-your-startup-cant-afford-to-ignore-it/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/michael-moedritzer.jpgMichael-Moedritzer2025-09-09T13:46:28+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/09/the-needle-issue-14/2025-09-09T13:34:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/experience-the-innovation-at-resi-boston-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/09/resi-bos-ipcs.jpgRESI-BOS-IPCshttps://blog.lifesciencenation.com/wp-content/uploads/2025/09/email-banner-25-26.jpgEmail-Banner-25-26https://blog.lifesciencenation.com/wp-content/uploads/2025/09/ci09032025.jpgCI090320252025-09-03T16:04:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/corporate-vc-panel-venture-and-innovation-arms-making-strategic-investments/2025-09-03T15:55:04+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/free-pre-resi-event-structuring-your-startup-legal-tax-funding-and-strategic-decisions/2025-09-03T15:54:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/hot-investor-mandate-europe-based-vc-firm-invests-through-seed-to-growth-stage-life-science-companies-across-the-globe-with-preference-for-therapeutics-and-platform-technologies/2025-09-03T15:51:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/hot-investor-mandate-investment-firm-with-global-interests-seeks-novel-disruptive-therapeutics-and-platform-technologies-from-pre-seed-to-series-a/2025-09-03T15:50:27+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/hot-investor-mandate-usa-based-vc-firm-invests-in-seed-stage-life-science-companies-with-a-focus-on-companies-in-longevity-and-ai/2025-09-03T15:49:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/hot-investor-mandate-seed-stage-investor-focuses-on-pre-clinical-drug-discovery-companies-in-cns-oncology-and-other-indications-supporting-them-for-clinical-readiness/2025-09-03T15:48:17+00:00monthlyhttps://blog.lifesciencenation.com/2025/09/03/the-needle-issue-13/2025-09-03T11:52:58+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/hot-investor-mandate-corporate-venture-arm-of-global-manufacturing-company-makes-strategic-investments-in-medical-devices-diagnostics-and-biomanufacturing/2025-08-26T16:23:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/hot-investor-mandate-usa-based-vc-firm-seeks-novel-therapeutics-and-platform-technologies-investing-up-to-30m-over-company-lifecycle/2025-08-26T16:22:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/hot-investor-mandate-venture-and-growth-investment-firm-seeks-early-stage-life-sciences-companies-in-the-us-open-to-all-sectors/2025-08-26T16:21:56+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/hot-investor-mandate-early-stage-vc-firm-invests-in-medtech-companies-in-seed-to-series-a-rounds-seeking-companies-across-the-globe/2025-08-26T16:21:27+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/investor-panels-at-resi-boston-september-2/2025-08-26T13:44:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/innovators-pitch-challenge-applications-now-open-for-resi-london-and-resi-jpm/2025-08-26T13:43:57+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/26/navigating-the-fda-why-early-strategic-planning-is-critical/https://blog.lifesciencenation.com/wp-content/uploads/2025/08/claire-davies.jpgClaire-Davies2025-08-26T13:43:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/resi-europe-moves-to-portugal-on-march-23-2026/https://blog.lifesciencenation.com/wp-content/uploads/2025/08/resi-europe-2026-1100px.jpgRESI-Europe-2026---1100px2025-08-19T16:03:04+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/impact-investors-venture-philanthropy-panel/2025-08-19T16:02:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/hot-investor-mandate-cross-border-vc-firm-invests-10-20m-in-early-stage-therapeutics-and-later-stage-medical-devices-in-us-and-china/2025-08-19T15:59:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/hot-investor-mandate-usa-based-seed-fund-invests-in-software-enabled-health-technologies-with-expanding-interests-in-traditional-life-science-companies/2025-08-19T15:59:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/hot-investor-mandate-cross-border-investment-firm-seeks-therapeutics-and-medical-technologies-investing-from-seed-to-pre-ipo/2025-08-19T15:59:39+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/hot-investor-mandate-multi-stage-generalist-seed-fund-invests-globally-in-value-based-life-sciences-and-healthcare-companies/2025-08-19T15:59:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/longevity-global-shapes-the-longevity-track-at-resi-boston/https://blog.lifesciencenation.com/wp-content/uploads/2025/08/justin-lg.jpgJustin-(LG)2025-08-19T14:32:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/19/pullans-pieces-4-january-a-corner-on-market-sentiments-seed-to-series-a/2025-08-19T14:13:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/investing-in-early-stage-diagnostics-innovation/2025-08-12T13:30:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/recent-life-sciences-deal-trends/2025-08-12T13:30:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/advancing-early-stage-drug-discovery-with-mosaic-biosciences/2025-08-12T13:30:07+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/hot-investor-mandate-vc-managing-multiple-usd-funds-invests-from-seed-to-pre-ipo-stage-across-novel-therapeutics-and-ai-driven-healthcare-with-focus-on-companies-with-china-angle/2025-08-12T13:28:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/hot-investor-mandate-us-seed-and-series-a-investment-firm-seeks-new-opportunities-in-therapeutics-medical-devices-diagnostics-digital-health/2025-08-12T13:28:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/hot-investor-mandate-usa-based-vc-seeks-early-and-late-stage-medical-devices-diagnostics-and-healthcare-it-accelerating-care-delivery/2025-08-12T13:28:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/hot-investor-mandate-early-stage-focused-vc-invests-in-pre-seed-and-seed-stage-deeptech-companies-including-synbio-and-data-driven-technologies/2025-08-12T13:28:41+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/12/the-needle-issue-12/2025-08-12T12:47:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/hot-investor-mandate-vc-fund-with-us-and-china-operations-seeks-to-invest-in-seed-to-growth-stage-medical-devices-diagnostics-and-digital-health/2025-08-05T15:45:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/hot-investor-mandate-china-based-investment-firm-backs-companies-and-funds-with-strong-interest-in-therapeutics-and-medtech-companies-with-local-market-fit/2025-08-05T15:45:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/hot-investor-mandate-early-stage-vc-focused-on-deeptech-innovation-investing-in-platform-and-enabling-technologies-from-pre-seed-to-series-a/2025-08-05T15:45:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/hot-investor-mandate-canada-based-vc-invests-in-ai-driven-technologies-including-medical-devices-diagnostics-and-digital-health-across-the-globe/2025-08-05T15:45:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/partnering-launches-august-11-for-resi-boston-september/https://blog.lifesciencenation.com/wp-content/uploads/2025/08/resi-bos-lon-jpm.jpgRESI-Bos-lon-jpm2025-08-05T15:23:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/chinas-biotech-boom-innovation-influence-and-rising-tensions/2025-08-05T13:48:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/get-on-pharmas-radar-what-big-companies-look-for-in-early-stage-innovation/2025-08-05T13:46:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/08/05/pullans-pieces-4-china-japan-europe-korea-vs-us-collaborate-or-compete/2025-08-05T13:41:04+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/why-impactful-storytelling-isnt-optional-in-life-sciences/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/tinotenda-chanakira.jpgTinotenda-Chanakira2025-07-29T16:18:07+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/jpm-2026-partnering-event-reception-space-available-at-resi-jpm/2025-07-29T15:29:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/beyond-the-pitch-why-life-science-startups-fail-and-how-bd-assist-closes-the-execution-gap/2025-07-29T15:29:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/pullans-pieces-3-january-a-corner-on-market-sentiments-seed-to-series-a/2025-07-29T12:25:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/hot-investor-mandate-vc-firm-headquartered-in-asia-makes-early-to-expansion-stage-investments-into-digital-healthcare-companies-with-asia-market-potential/2025-07-29T12:19:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/hot-investor-mandate-venture-arm-of-investment-bank-seek-therapeutics-and-medtech-companies-in-cns-oncology-and-more-focusing-on-us-based-opportunities/2025-07-29T12:19:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/hot-investor-mandate-vc-firm-focuses-on-global-early-stage-medical-device-investments-with-strong-interest-in-companies-developing-class-iii-devices/2025-07-29T12:19:44+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/29/hot-investor-mandate-usa-based-early-stage-venture-fund-invests-in-seed-stage-companies-with-opportunistic-interests-across-life-sciences/2025-07-29T12:19:42+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/london-life-sciences-partnering-venture-investment-week/2025-07-22T16:25:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/hot-investor-mandate-investing-holding-company-backed-by-leading-european-institutions-seeks-europe-and-us-based-companies-in-all-life-science-sectors/2025-07-22T16:00:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/hot-investor-mandate-global-manufacturing-company-seeks-strategic-partnerships-with-early-stage-medical-device-and-digital-health-companies-across-the-globe/2025-07-22T15:59:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/hot-investor-mandate-us-based-vc-invests-in-tech-bio-companies-achieving-breakthroughs-in-drug-development-precision-medicine-and-more-across-all-indications/2025-07-22T15:59:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/hot-investor-mandate-early-stage-vc-invests-in-transformative-technologies-across-the-globe-that-address-mental-health-challenges/2025-07-22T15:58:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/pharma-tariff-article-200-pharma-tariff-threat-impacts-on-biotech-venture-investment/2025-07-22T15:15:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/mantabio-resi-boston-pitch-challenge-winner-shares-whats-next/2025-07-22T15:09:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/22/the-needle-issue-11/2025-07-22T13:45:42+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/inomagen-therapeutics-resi-boston-june-ipc-winner/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/eric-sandberg.jpgEric-Sandberg2025-07-15T20:26:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/hot-investor-mandate-global-pharma-innovation-arm-invests-in-early-stage-innovations-in-digital-therapeutics-neurotech-and-more-across-north-america-and-europe/2025-07-15T15:11:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/hot-investor-mandate-vc-firm-backed-by-major-financial-services-group-seeks-co-investment-opportunities-in-early-stage-therapeutics-and-medtech-sectors/2025-07-15T15:11:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/hot-investor-mandate-europe-based-vc-seeks-pre-seed-to-series-a-innovations-in-biotech-and-digital-health-with-a-focus-on-nordic-and-baltic-regions/2025-07-15T15:10:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/hot-investor-mandate-north-america-based-vc-backs-early-stage-ai-enabled-healthtech-companies-with-flexible-capital-structures/2025-07-15T15:10:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/get-fundraising-ready-before-biospain-2025-exclusive-startup-workshops-in-barcelona/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/biospain-course-banner.jpgBIOSPAIN-COURSE-BANNER2025-07-15T13:43:09+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/free-pre-resi-boston-event-structuring-your-startup-legal-tax-funding-and-other-strategic-decisions/2025-07-15T13:43:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/pullans-pieces-2-top-drug-sellers-by-geo/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/04.png04https://blog.lifesciencenation.com/wp-content/uploads/2025/07/03.png03https://blog.lifesciencenation.com/wp-content/uploads/2025/07/02.png02https://blog.lifesciencenation.com/wp-content/uploads/2025/07/01.png012025-07-15T12:00:27+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/15/the-needle-issue-10/2025-07-15T11:57:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/hot-investor-mandate-us-based-vc-firm-seeks-new-therapeutics-and-medical-device-investment-opportunities-investing-up-to-20m/2025-07-08T15:11:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/hot-investor-mandate-vc-firm-invests-up-to-e20m-in-us-and-europe-based-device-diagnostics-and-digital-health-companies/2025-07-08T15:11:41+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/hot-investor-mandate-global-investment-firm-seeks-early-stage-healthcare-companies-including-devices-and-digital-health-targeting-diabetes-and-related-conditions/2025-07-08T15:11:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/hot-investor-mandate-us-based-vc-firm-invests-in-seed-to-series-a-medical-device-companies-backed-by-female-and-minority-founding-teams/2025-07-08T15:11:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/introducing-bioventure-voices-a-new-segment-in-next-phase/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/screenshot-2025-07-08-103348.pngScreenshot 2025-07-08 1033482025-07-08T15:06:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/resi-boston-webinar-series-your-roadmap-to-a-stronger-pitch-smarter-partnering-and-greater-investor-engagement/2025-07-08T15:04:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/08/meet-the-first-place-winner-of-resi-bostons-innovators-pitch-challenge-mindlab/2025-07-08T13:44:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/hot-investor-mandate-subsidiary-of-china-based-enterprise-partners-with-and-invests-in-clinical-stage-biotech-and-rd-enabling-technologies-investing-up-to-100m/2025-07-01T15:35:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/hot-investor-mandate-private-investment-firm-seeks-seed-stage-investment-opportunities-in-medical-devices-and-digital-health-across-the-globe/2025-07-01T15:35:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/hot-investor-mandate-venture-arm-of-foundation-invests-in-seed-to-series-a-life-science-technologies-that-address-brain-cancer-and-adjacent-cns-diseases/2025-07-01T15:35:07+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/hot-investor-mandate-pre-seed-and-seed-stage-focused-fund-seeks-usa-based-medical-device-and-digital-health-technologies-in-cardiology-womens-health-and-more/2025-07-01T15:35:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/announcing-premier-plus-for-resi-partnering/2025-07-01T14:45:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/new-aging-longevity-track-launches-at-resi-boston-via-partnership-between-longevity-global-and-life-science-nation/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/resi-new.jpgRESI-newhttps://blog.lifesciencenation.com/wp-content/uploads/2025/07/longevity-global.jpgLONGEVITY-GLOBALhttps://blog.lifesciencenation.com/wp-content/uploads/2025/07/matt-blog.jpgMatt-blog2025-07-01T14:45:18+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/why-startups-struggle-to-get-investor-meetings-and-how-to-fix-it-2/2025-07-01T13:54:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/pullans-pieces-1-organ-on-a-chip/https://blog.lifesciencenation.com/wp-content/uploads/2025/07/1474561932612-wmt3ce26uhp6mb2t-9055c7e2174b93c8347af801920cbb23.png1474561932612-wmt3ce26uhp6mb2t-9055c7e2174b93c8347af801920cbb23https://blog.lifesciencenation.com/wp-content/uploads/2025/07/image.pngimage2025-07-01T13:50:53+00:00monthlyhttps://blog.lifesciencenation.com/2025/07/01/the-needle-issue-9/2025-07-01T13:40:58+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/investor-panels-at-resi-boston-september/https://blog.lifesciencenation.com/wp-content/uploads/2025/06/resi-bos-to-jpm-banner.jpgRESI-Bos-to-JPM-Banner2025-06-24T17:16:58+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/hot-investor-mandate-europe-based-vc-firm-invests-up-to-25-30m-over-the-company-lifecycle-for-those-addressing-oncology-or-genetic-diseases-across-the-globe/2025-06-24T16:05:56+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/hot-investor-mandate-healthcare-focused-vc-firm-invests-in-promising-companies-in-north-and-south-america-across-all-life-science-sectors/2025-06-24T16:05:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/hot-investor-mandate-corporate-vc-firm-invests-in-medtech-and-digital-health-companies-in-areas-of-chronic-diseases-and-conditions-emergency-medicine-and-more/2025-06-24T16:05:40+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/hot-investor-mandate-us-and-china-based-cross-border-vc-firm-seeks-to-invest-in-novel-therapeutics-and-enabling-technologies-globally-from-seed-to-growth/2025-06-24T16:05:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/resi-boston-ipc-winners-announced-now-accepting-applications-for-september/https://blog.lifesciencenation.com/wp-content/uploads/2025/06/img_1154.jpegIMG_1154https://blog.lifesciencenation.com/wp-content/uploads/2025/06/img_1147.jpegIMG_1147https://blog.lifesciencenation.com/wp-content/uploads/2025/06/img_1145.jpegIMG_1145https://blog.lifesciencenation.com/wp-content/uploads/2025/06/inomagen.jpgInomagenhttps://blog.lifesciencenation.com/wp-content/uploads/2025/06/mantabio.pngmantaBiohttps://blog.lifesciencenation.com/wp-content/uploads/2025/06/mindlab.jpgMindLab2025-06-24T15:32:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/introducing-bd-assist-lsn-sets-up-the-meetings-for-your-global-investor-roadshow/2025-06-24T15:31:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/24/the-needle-issue-8/2025-06-24T14:55:36+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/navigating-cfius-awareness-and-opportunity-for-biotech-startups-in-a-changing-investment-landscape/2025-06-10T15:12:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/introducing-the-investor-judges-for-the-innovators-pitch-challenge-at-resi-boston/2025-06-10T15:10:01+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/introduction-to-the-resi-boston-june-2025-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2025/06/print-version-for-review-only-resi-boston-june-2025-program-guide-1.jpg[Print version for review only] RESI Boston June 2025 Program Guide-12025-06-10T13:22:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/the-needle-issue-7/2025-06-10T12:53:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/hot-investor-mandate-venture-arm-of-global-pharma-invests-in-life-science-and-healthcare-companies-with-strong-interest-in-womens-health-solutions/2025-06-10T12:52:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/hot-investor-mandate-vc-in-middle-east-makes-pre-seed-and-seed-stage-investments-in-medical-device-diagnostics-and-digital-health-companies/2025-06-10T12:52:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/hot-investor-mandate-multinational-life-sciences-corporation-invests-and-partners-with-diagnostics-life-science-tools-and-techbio-companies-in-us-and-europe/2025-06-10T12:52:29+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/10/hot-investor-mandate-early-stage-focused-vc-firm-invests-in-devices-diagnostics-and-digital-therapeutics-companies-in-the-us/2025-06-10T12:52:28+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/case-study-brisbanes-accelerator-model-thats-raising-capital-and-elevating-medtech/2025-06-06T00:40:13+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/hot-investor-mandate-healthcare-business-of-large-corporation-seeks-medical-devices-diagnostics-and-digital-health-companies-across-the-globe/2025-06-03T14:59:16+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/hot-investor-mandate-boutique-vc-firm-with-evergreen-fund-invests-in-therapeutics-and-medical-devices-generally-in-series-a-and-b-rounds/2025-06-03T14:59:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/hot-investor-mandate-usa-based-vc-invests-up-to-10m-in-digital-health-and-healthcare-services-advancing-better-health-outcomes/2025-06-03T14:58:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/hot-investor-mandate-asia-based-private-investment-vehicle-invests-across-all-life-science-sectors-from-pre-seed-to-series-a-rounds/2025-06-03T14:58:26+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/engineering-breakthroughs-how-tecan-partners-with-medtech-innovators-to-scale-smarter/https://blog.lifesciencenation.com/wp-content/uploads/2025/06/jed-palmer.jpgJed-Palmer2025-06-03T14:26:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/the-heros-journey-a-ceos-mission-to-find-a-cure-to-save-his-sons-part-ii/2025-06-03T14:23:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/06/03/resi-boston-june-investor-panelists/2025-06-03T13:54:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/meet-the-finalists-14-sessions-of-cutting-edge-innovation-at-the-resi-boston-june-innovators-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2025/05/resi-boston-june-ipc-new.jpgRESI Boston June IPC newhttps://blog.lifesciencenation.com/wp-content/uploads/2025/05/resi-june-ipc-finalists.jpgRESI-JUNE-IPC-Finalistshttps://blog.lifesciencenation.com/wp-content/uploads/2025/05/resi-boston-june-ipc.jpgRESI Boston June IPC2025-05-29T13:46:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/hot-investor-mandate-public-company-with-corporate-venture-fund-seeks-to-invest-up-to-10m-in-medical-device-companies-with-china-market-potential/2025-05-28T17:42:44+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/hot-investor-mandate-joint-venture-with-close-family-office-ties-invests-in-medical-devices-close-to-fda-approval-in-us-western-europe-korea-and-japan/2025-05-28T17:42:28+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/hot-investor-mandate-western-europe-based-vc-seeks-therapeutics-investment-opportunities-across-the-globe-with-strong-interest-in-targeted-therapies/2025-05-28T17:42:10+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/hot-investor-mandate-early-stage-vc-fund-invests-in-pre-seed-and-seed-stage-companies-in-therapeutics-diagnostics-life-science-tools/2025-05-28T17:41:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/beyond-big-pharma-panel-at-resi-boston-june/2025-05-28T16:30:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/the-heros-journey-a-ceos-mission-to-find-a-cure-to-save-his-sons/2025-05-28T15:29:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/28/the-needle-issue-5/2025-05-28T11:47:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/hot-investor-mandate-venture-arm-of-global-pharma-invests-in-pre-seed-and-seed-stage-companies-most-interested-in-therapeutics-and-data-driven-technologies/2025-05-20T14:50:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/hot-investor-mandate-vc-arm-of-service-provider-company-seeks-to-invest-in-us-and-europe-based-therapeutics-companies-from-seed-to-series-b/2025-05-20T14:49:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/hot-investor-mandate-corporate-venture-arm-of-global-corporation-invests-up-to-20m-in-all-life-science-sectors-focusing-on-areas-of-major-unmet-medical-need/2025-05-20T14:49:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/hot-investor-mandate-europe-based-vc-looks-for-medical-devices-diagnostics-and-digital-health-investment-opportunities-from-seed-to-series-b/2025-05-20T14:49:08+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/biometas-and-life-science-nation-form-global-accelerator-alliance-to-transform-early-stage-therapeutics/2025-05-20T13:59:56+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/prep-for-bio-resi-with-the-lsn-pharma-bd-directory/2025-05-20T13:53:16+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/aging-and-longevity-investing-for-healthier-lifespans/2025-05-20T13:53:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/20/the-needle-issue-4/2025-05-20T12:34:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/global-family-office-bioforum-at-resi-boston-june-where-active-investors-connect-and-collaborate/2025-05-13T15:08:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/hot-investor-mandate-healthcare-vc-firm-invests-in-global-oncology-immunology-chronic-disease-therapeutics-innovations-from-series-a-and-beyond/2025-05-13T15:05:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/hot-investor-mandate-impact-fund-invests-in-usa-europe-based-life-science-companies-with-strong-interests-in-therapeutics-drug-delivery-cns-and-oncology/2025-05-13T15:05:55+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/hot-investor-mandate-multi-family-office-venture-fund-invests-in-medical-technology-and-life-science-tools-companies-with-focus-on-west-coast-usa/2025-05-13T15:05:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/hot-investor-mandate-healthcare-focused-vc-fund-seeks-early-stage-medical-device-and-digital-health-technologies-in-the-us/2025-05-13T15:05:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/mark-your-calendar-june-15-event-helps-global-startups-land-in-the-boston-life-science-ecosystem/2025-05-13T14:00:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/13/the-needle-issue-3/2025-05-13T12:37:40+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/hot-investor-mandate-global-investment-management-firm-seeks-to-invest-up-to-10m-in-first-in-class-and-best-in-class-therapeutics-devices-and-diagnostics/2025-05-06T14:47:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/hot-investor-mandate-life-science-focused-vc-looks-for-early-stage-therapeutics-devices-and-diagnostics-companies-in-us-and-europe-with-focus-in-europe/2025-05-06T14:47:37+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/hot-investor-mandate-pharmaceutical-company-seeks-strategic-partnering-and-investment-opportunities-in-small-molecules-and-biologics-globally/2025-05-06T14:47:29+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/hot-investor-mandate-usa-based-vc-firm-invests-in-disruptive-digital-health-solutions-with-transformational-potential-in-healthcare/2025-05-06T14:47:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/early-bird-innovators-pitch-challenge-deadlines-this-week-for-resi-boston-june/2025-05-06T14:41:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/redefining-emergency-care-an-interview-with-opportunity-health/https://blog.lifesciencenation.com/wp-content/uploads/2025/05/inigo-almazan-tife.jpgIñigo-Almazán-Tife2025-05-06T13:27:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/05/06/resi-returns-to-london-december-4-6-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/05/resi-london-2025-with-biometas.jpgRESI-London-2025-with-Biometas2025-05-06T13:27:41+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/introducing-haystack-corner-insights-from-juan-carlos-lopez-and-andrew-marshall-of-haystack-science/https://blog.lifesciencenation.com/wp-content/uploads/2025/04/haystack-corner.jpgHaystack-Corner2025-04-29T14:47:56+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/learn-why-innovators-pitch-at-resi-boston-this-june/2025-04-29T14:21:55+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/hot-investor-mandate-pharma-company-seeks-in-licensing-and-co-development-opportunities-with-antibody-based-therapeutics-across-the-globe/2025-04-29T14:12:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/hot-investor-mandate-family-office-backed-vc-firm-invests-in-therapeutics-diagnostics-and-digital-health-companies-open-to-global-opportunities/2025-04-29T14:12:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/hot-investor-mandate-usa-based-seed-fund-invests-in-ai-driven-healthcare-technologies-including-diagnostics-digital-health-life-science-tools/2025-04-29T14:12:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/hot-investor-mandate-asia-based-investment-firm-seeks-seed-to-pre-series-a-opportunities-broadly-across-all-life-science-and-healthcare-sectors/2025-04-29T14:12:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/29/seed-funding-hits-lows-investor-pull-back-sentiment-down-but-opportunities-remain-for-the-savvy/2025-04-29T12:47:57+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/hot-investor-mandate-cvc-arm-of-global-cdmo-seeking-co-investment-opportunities-from-seed-to-ipo-in-biotech-open-to-biologics-antibodies-proteins-dna-rna-vaccines-and-more/2025-04-22T16:34:06+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/hot-investor-mandate-u-s-based-venture-capital-firm-backed-by-health-system-seeks-medical-technologies-to-improve-quality-and-health-outcomes/2025-04-22T16:34:04+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/hot-investor-mandate-asia-based-private-equity-firm-invests-opportunistically-in-life-sciences-including-therapeutics-medical-devices-digital-health-and-diagnostics/2025-04-22T16:34:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/hot-investor-mandate-u-s-based-venture-capital-firm-interested-in-pre-seed-to-series-a-opportunities-in-ai-for-healthcare-diagnostics-and-medical-devices/2025-04-22T16:34:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/meet-meki-durakovic-the-hospitality-force-behind-bostons-culinary-hotspots/https://blog.lifesciencenation.com/wp-content/uploads/2025/04/meki-durakovic.jpgMeki-Durakovic2025-04-22T15:06:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/mowoot-wins-resi-europe-2025-innovators-pitch-challenge-ipc/https://blog.lifesciencenation.com/wp-content/uploads/2025/04/markus-wilhelms.jpgMarkus-Wilhelms2025-04-22T12:50:38+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/22/why-do-90-of-life-science-startups-fail-because-the-science-never-gets-out-of-the-way/2025-04-22T12:16:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/how-family-offices-are-cracking-the-code-on-biotech-investing/https://blog.lifesciencenation.com/wp-content/uploads/2025/04/rick-berenson.jpgRick-Berensonhttps://blog.lifesciencenation.com/wp-content/uploads/2025/04/chris-garabedian.jpgChris-Garabedianhttps://blog.lifesciencenation.com/wp-content/uploads/2025/04/img_0688.jpegPhotographerAll rights reserved by Gulnara Niaz. For personal use only - this image, or derivative works, can not be used, published, distributed or sold without written permission of the owner. (All rights reserved by Gulnara Niaz. For personal use only - this i2025-04-15T19:25:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/hot-investor-mandate-global-life-science-focused-fund-invests-in-therapeutics-medical-device-diagnostics-companies-addressing-unmet-medical-need/2025-04-15T15:48:07+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/hot-investor-mandate-international-asset-management-firm-invests-up-to-50m-in-therapeutics-devices-and-healthtech-companies-with-us-and-china-market-potential/2025-04-15T15:48:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/hot-investor-mandate-life-science-focused-vc-firm-invests-in-early-stage-usa-based-life-science-companies-across-all-sectors-and-indications/2025-04-15T15:48:03+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/hot-investor-mandate-usa-based-investment-firm-seeks-early-and-growth-stage-companies-in-medical-devices-diagnostics-and-digital-health-in-underserved-regions/2025-04-15T15:48:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/the-trump-pharmaceutical-tariffs-latest-developments/2025-04-15T13:00:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/15/meet-bostons-life-science-leaders-soft-landing-event-and-reception/2025-04-15T13:00:20+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/xontogenys-garabedian-must-watch-interview-getting-discovered-fundraising-outlook-more/2025-04-08T15:55:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/resi-europe-2025-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2025/04/darwin-biomed.jpgDARWIN-Biomedhttps://blog.lifesciencenation.com/wp-content/uploads/2025/04/opportunity-health-sl.jpgOpportunity-Health-SLhttps://blog.lifesciencenation.com/wp-content/uploads/2025/04/mowoot.jpgMOWOOThttps://blog.lifesciencenation.com/wp-content/uploads/2025/04/resi-25-26-banner-2000px-w.jpgRESI-25-26-Banner-2000px-w2025-04-08T13:05:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/resi-boston-returns-june-16-18-connect-with-top-investors-and-life-science-leaders/2025-04-08T13:04:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/hot-investor-mandate-global-pharmaceutical-company-seeks-partnerships-with-early-stage-therapeutics-companies-developing-biologics/2025-04-08T13:02:24+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/hot-investor-mandate-usa-based-digital-health-fund-looking-to-invest-in-seed-stage-startups/2025-04-08T13:02:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/hot-investor-mandate-japanese-cross-border-vc-firm-invests-in-therapeutic-startups-worldwide/2025-04-08T13:02:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/04/08/hot-investor-mandate-uk-based-vc-firm-seeks-investments-in-women-led-health-tech-startups/2025-04-08T13:02:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/26/why-resi-europe-in-barcelona-is-the-bridge-the-life-science-industry-needs/2025-03-26T19:49:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/26/why-startups-struggle-to-get-investor-meetings-and-how-to-fix-it/2025-03-26T19:08:27+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/26/life-science-nation-presents-the-resi-europe-2025-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-europe-pg-cover.jpgRESI Europe PG Cover2025-03-26T19:07:06+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/insights-from-the-investor-fireside-chat-on-life-science-fundraising/2025-03-18T22:29:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/biometas-named-title-sponsor-for-resi-partnering-events-in-2025-and-2026/https://blog.lifesciencenation.com/wp-content/uploads/2025/03/lsn.jpglsnhttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/biometas.jpgBioMetashttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/biometas-logo.jpgBioMetas Logohttps://blog.lifesciencenation.com/wp-content/uploads/2022/12/df-news-09142022.jpgDF-News-09142022https://blog.lifesciencenation.com/wp-content/uploads/2014/02/cropped-logo-final-big.pngcropped-logo-final-big.png2025-03-18T17:19:26+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/hot-investor-mandate-usa-based-family-office-invests-in-pre-seed-to-series-a-companies-in-the-fields-of-cns-and-neurodegenerative-diseases/2025-03-18T17:17:25+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/hot-investor-mandate-vc-firm-with-china-headquarters-seeks-innovative-therapeutics-devices-and-diagnostics-companies-across-the-globe/2025-03-18T17:17:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/hot-investor-mandate-usa-based-vc-firm-invests-in-all-life-science-and-healthtech-sectors-across-pre-seed-seed-and-series-a-rounds/2025-03-18T17:17:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/hot-investor-mandate-china-based-vc-firm-invests-in-early-stage-therapeutics-and-digital-health-companies-interested-in-china-market-entry/2025-03-18T17:17:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/18/investor-panelists-at-resi-europe-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-europe-2025-with-biometas.jpgRESI-Europe-2025-with-Biometashttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-london-2025-with-biometas.jpgRESI-London-2025-with-Biometashttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-boston-2025-june-with-biometas.jpgRESI-Boston-2025-June-with-BioMetashttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-jpm-2026-with-biometas.jpgRESI-JPM-2026-with-Biometashttps://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-boston-2025-september-with-biometas.jpgRESI-Boston-2025-September-with-Biometas2025-03-18T16:18:29+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/13/interview-with-resi-jpm-sponsor-bullfrog-ai/2025-03-13T20:05:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/partnering-is-open-for-resi-europe-connect-with-global-investors/2025-03-11T17:41:40+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/unprecedented-growth-of-life-science-investment-startups-in-catalonia-barcelona/2025-03-11T17:37:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/hot-investor-mandate-asia-based-vc-firm-invests-in-early-and-growth-stage-medtech-digital-health-and-technologies-leveraging-ai-on-a-global-scale/2025-03-11T17:21:53+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/hot-investor-mandate-vc-firm-invests-in-medical-devices-software-enabled-healthtech-and-deeptech-with-focus-on-europe-based-companies/2025-03-11T17:21:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/hot-investor-mandate-usa-based-vc-firm-seeks-life-science-and-deeptech-companies-investing-in-over-20-companies-per-year-across-the-globe/2025-03-11T17:21:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/hot-investor-mandate-vc-firm-invests-in-seed-and-series-a-rounds-in-womens-health-companies-focusing-on-europe-middle-east-and-us/2025-03-11T17:21:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/11/helping-founders-prepare-for-investment-a-conversation-with-juan-carlos-lopez-and-andy-marshall-of-haystack-sciences/2025-03-11T16:49:35+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/how-ukraine-affects-global-life-science-innovation/2025-03-04T18:58:57+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/european-technology-hubs-will-be-in-the-spotlight-at-resi-europe/2025-03-04T18:51:22+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/resi-europe-2025-innovators-pitch-challenge-finalists/https://blog.lifesciencenation.com/wp-content/uploads/2025/03/resi-europe-ipc-03042025.jpgRESI-Europe-IPC-030420252025-03-04T18:47:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/hot-investor-mandate-vc-firm-with-offices-in-us-and-china-invests-in-all-life-science-sectors-from-seed-to-series-b/2025-03-04T18:24:55+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/hot-investor-mandate-vc-firm-with-us-and-india-operations-invests-up-to-10m-in-therapeutics-and-medical-device-companies-across-the-globe/2025-03-04T18:24:53+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/hot-investor-mandate-life-sciences-focused-vc-invests-15m-over-company-lifecycle-seeks-promising-therapeutics-devices-and-diagnostics-in-us-and-canada/2025-03-04T18:24:51+00:00monthlyhttps://blog.lifesciencenation.com/2025/03/04/hot-investor-mandate-corporate-venture-fund-seeks-innovative-therapeutics-and-platform-technologies-based-in-us-and-europe/2025-03-04T18:24:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/hot-investor-mandate-medtech-and-digital-health-focused-vc-firm-seeks-to-make-new-investments-in-the-us-over-the-next-9-12-months/2025-02-25T18:48:11+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/hot-investor-mandate-french-vc-firm-with-us-office-seeking-early-stage-life-science-investment-opportunities-up-to-3m/2025-02-25T18:29:55+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/hot-investor-mandate-saudi-arabian-investment-firm-invests-5-10m-in-cell-and-gene-therapy-companies-offering-expertise-in-regional-and-international-markets/2025-02-25T18:29:52+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/hot-investor-mandate-vc-firm-invests-in-usa-based-medical-device-companies-addressing-cardiovascular-and-orthopedic-indications/2025-02-25T18:29:48+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/exploring-the-future-of-biotech-investment-the-therapeutics-panel-at-resi-europe/2025-02-25T15:51:41+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/25/fdas-med-device-staff-firings-industry-implications/2025-02-25T15:49:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/hot-investor-mandate-investment-firm-managing-multi-billion-aum-invests-up-to-25m-in-therapeutics-and-medial-device-companies-across-the-globe/2025-02-19T18:25:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/hot-investor-mandate-usa-based-vc-firm-invests-in-all-life-science-sectors-across-seed-to-series-b-rounds-most-interested-in-innovative-medical-devices/2025-02-19T17:07:19+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/hot-investor-mandate-vc-firm-with-us-middle-east-offices-invests-up-to-15m-in-life-science-technologies-with-focus-on-longevity/2025-02-19T17:07:17+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/hot-investor-mandate-family-office-with-healthtech-dedicated-fund-seeks-early-stage-us-based-digital-health-and-data-driven-healthcare-companies/2025-02-19T17:07:15+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/investors-meet-syndicates-at-resi/2025-02-19T16:39:40+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/china-the-new-darling-for-deals-with-trump-tariffs-looming/2025-02-19T16:12:04+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/19/innovating-cancer-treatment-interview-with-upythers-ceo-geert-van-almen/2025-02-19T16:11:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/hot-investor-mandate-vc-firm-with-us-china-offices-invests-5-15m-in-all-life-science-and-healthcare-companies-across-the-globe/2025-02-11T17:35:10+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/hot-investor-mandate-usa-based-vc-firm-invests-in-ai-leveraging-healthcare-companies-in-us-canada-and-uk/2025-02-11T17:28:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/hot-investor-mandate-vc-firm-seeks-seed-to-series-a-companies-working-on-data-driven-digital-health-and-techbio-technologies/2025-02-11T17:26:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/hot-investor-mandate-newly-founded-angel-group-looks-to-invest-in-early-stage-medical-device-and-digital-health-companies-in-the-us/2025-02-11T17:26:00+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/rfk-jr-trump-think-govt-grants-are-broken-are-they-the-problem-with-life-science-grant-funding/2025-02-25T21:16:23+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/meet-global-investors-at-resi-europe-in-barcelona/https://blog.lifesciencenation.com/wp-content/uploads/2025/02/ci02112025.jpgci02112025https://blog.lifesciencenation.com/wp-content/uploads/2025/02/ci2112025.jpgci21120252025-02-11T15:45:38+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/11/rhythm-biotherapeutics-innovators-pitch-challenge-winner-spotlight/2025-02-11T15:42:31+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/seventeen-startups-seven-unicorns-an-interview-with-thomas-forest-farb-horch-ceo-and-co-founder-thrive-bioscience-inc/2025-02-07T15:35:53+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/maximize-your-brands-exposure-with-resi-sponsorship-in-2025/2025-02-07T14:10:43+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/hot-investor-mandate-investment-arm-of-global-asset-management-firm-invests-up-to-20m-in-medical-device-and-digital-health-companies-focusing-on-us-and-europe/2025-02-04T17:40:14+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/hot-investor-mandate-vc-firm-with-close-ties-to-health-insurance-provider-seeks-investments-in-devices-diagnostics-digital-health-and-healthcare-services/2025-02-04T17:40:12+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/hot-investor-mandate-usa-based-vc-fund-invests-in-seed-to-series-a-companies-in-deeptech-and-cns-neuro-tech-across-all-life-science-sectors/2025-02-04T17:40:08+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/hot-investor-mandate-early-stage-focused-vc-firm-invests-in-therapeutics-companies-across-all-modalities-and-indications-with-focus-on-us-and-europe/2025-02-04T17:40:05+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/is-the-nih-freeze-thawing/2025-02-04T16:19:45+00:00monthlyhttps://blog.lifesciencenation.com/2025/02/04/conversation-with-rob-fraser-cso-president-and-co-founder-of-molecular-you-innovators-pitch-challenge-success-at-resi-jpm/2025-02-04T16:16:54+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/why-attend-resi-europe-barcelona/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/article-chart-04.jpgarticle-chart-04https://blog.lifesciencenation.com/wp-content/uploads/2025/01/article-chart-03.jpgarticle-chart-03https://blog.lifesciencenation.com/wp-content/uploads/2025/01/article-chart-01.jpgarticle-chart-01https://blog.lifesciencenation.com/wp-content/uploads/2025/01/article-chart-02.jpgarticle-chart-022025-01-28T19:30:02+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/hot-investor-mandate-single-family-office-makes-global-investments-in-therapeutics-companies-across-various-indications-from-seed-to-growth-stage/2025-01-28T17:19:01+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/hot-investor-mandate-vc-firm-invests-1-5m-in-drug-discovery-enabling-technologies-and-precision-medicine-companies-across-the-globe/2025-01-28T17:18:59+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/hot-investor-mandate-us-based-pharma-invests-and-partners-with-therapeutics-companies-in-immunology-orphan-diseases-and-other-indications/2025-01-28T17:18:57+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/hot-investor-mandate-corporate-venture-fund-seeks-seed-to-series-a-investments-in-companies-improving-human-health-including-microbiome-and-cognitive-function/2025-01-28T17:18:55+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/kimaritec-takes-first-place-in-the-innovators-pitch-challenge-at-resi-jpm/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/sally-stephenson.jpgSally-Stephenson2025-01-28T16:36:32+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/28/resi-europe-2025-investor-panel-lineup-announced/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/resi-europe-2025-investor-panels.pngRESI Europe 2025 Investor Panelshttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/resi-boston-2025-june-1100px.jpgRESI-Boston-2025-June-1100px2025-01-28T15:53:06+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/congratulations-to-the-innovators-pitch-challenge-winners-at-resi-jpm-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/3rd-place.jpg3rd placehttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/2nd-place.jpg2nd placehttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/1st-place.jpg1st place2025-01-22T19:31:27+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/exciting-partnership-milestone/2025-01-22T19:06:25+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/super-early-bird-rates-for-resi-europe-2025-end-january-31/2025-01-22T19:06:21+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/hot-investor-mandate-investment-firm-with-china-headquarters-invests-up-to-8m-in-therapeutics-devices-and-diagnostics-companies/2025-01-22T19:05:50+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/hot-investor-mandate-western-europe-based-vc-seeks-therapeutics-investment-opportunities-across-all-indications-and-modalities-in-us-and-europe/2025-01-22T19:05:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/hot-investor-mandate-strategic-investment-fund-of-global-conglomerate-invests-in-therapeutics-diagnostics-and-enabling-technologies-in-series-a-and-b/2025-01-22T19:05:47+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/22/hot-investor-mandate-usa-based-vc-invests-in-therapeutics-devices-and-digital-health-wellness-companies-targeting-cns-mental-behavioral-diseases-and-more-2/2025-01-22T19:05:46+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/companies-to-watch-2025/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/servatus-ltd.jpgServatus-Ltdhttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/eywa-biotech.jpgEywa-Biotechhttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/wellumio.jpgWellumiohttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/eysz-inc.jpgEysz-Inchttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/guideai-health.jpgGuideAI-Healthhttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/gate2brain.jpgGate2Brainhttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/in8bio.jpgIN8biohttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/vntc-n.jpgVNTC--Nhttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/vntc.jpgVNTChttps://blog.lifesciencenation.com/wp-content/uploads/2025/01/serenatis-bio.jpgSerenatis-Bio2025-01-09T09:27:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/hot-investor-mandate-global-vc-fund-seeks-first-in-class-best-in-class-innovations-in-microbiome-phage-therapy-gene-editing-and-more/2025-01-07T17:00:34+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/hot-investor-mandate-uk-based-vc-firm-seeks-medical-devices-diagnostics-and-digital-therapeutics-companies-focusing-on-europe-and-israel/2025-01-07T17:00:33+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/hot-investor-mandate-vc-firm-with-offices-in-us-and-asia-seeks-therapeutics-diagnostics-and-digital-health-companies-investing-up-to-10m/2025-01-07T17:00:31+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/hot-investor-mandate-private-investment-firm-seeks-therapeutics-platforms-and-enabling-technologies-tools-companies-investing-in-seed-to-series-a/2025-01-07T17:00:30+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/sougato-das-joins-lsn-as-president-and-chief-operating-officer/https://blog.lifesciencenation.com/wp-content/uploads/2025/01/sougato-das.jpgSougato-Das2025-01-07T15:51:49+00:00monthlyhttps://blog.lifesciencenation.com/2025/01/07/beyond-sbirs-non-dilutive-funding-strategies-to-advance-your-pipeline-and-bottom-line/2025-01-07T15:51:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/31/life-science-nation-lsn-announces-the-resi-jpm-program-guide-celebrating-the-50th-resi-conference-at-its-new-location-the-san-francisco-marriott-marquis/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/resi-jpm-2025-program-guide_cover.jpgRESI-JPM-2025-Program-Guide_Cover2024-12-31T14:22:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/31/resi-europe-2025-returns-to-barcelona/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/resi-europe-2025-1100-1.jpgRESI-Europe-2025-1100 (1)2024-12-31T14:22:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/31/rinri-therapeutics-pioneering-solutions-for-sensorineural-hearing-loss/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/simon-chandler.jpgSimon-Chandler2024-12-31T14:22:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/brisbanes-medtech-ascent-driving-global-healthcare-innovation/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/anthony-ryan.jpgAnthony-Ryan2024-12-20T13:01:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/resi-jpm-celebrating-50-conferences-and-redefining-every-stage-of-investment/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/resi-50th-logo.jpgRESI-50TH-Logo2024-12-17T18:31:06+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/resi-panelists-at-resi-jpm-2025/2024-12-17T17:33:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/hot-investor-mandate-corporate-venture-arm-of-global-supplier-invests-in-life-science-companies-of-all-stages-strong-interests-in-aging-and-chronic-disease/2024-12-17T16:30:22+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/hot-investor-mandate-vc-firm-with-single-lp-invests-up-to-15m-in-growth-stage-healthcare-companies-in-us-and-canada/2024-12-17T16:30:19+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/hot-investor-mandate-healthcare-focused-growth-equity-firm-invests-in-all-life-science-sectors-focusing-on-later-stage-opportunities-close-to-commercialization/2024-12-17T16:30:17+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/17/hot-investor-mandate-new-hedge-fund-subsidiary-invests-in-pre-seed-to-series-a-startups-in-us-and-europe-most-interested-in-diagnostics-and-healthtech-technologies/2024-12-17T16:30:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/03/rfk-jr-as-hhs-head-biotech-investment-implications/2024-12-10T17:29:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/10/hot-investor-mandate-private-investment-firm-with-multi-billion-aum-seeks-to-make-equity-investments-across-all-life-science-sectors-with-focus-on-therapeutics/2024-12-10T17:25:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/10/hot-investor-mandate-pre-seed-and-seed-stage-focused-vc-firm-invests-in-synthetic-biology-and-life-science-companies-leveraging-ai-and-technology/2024-12-10T17:25:37+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/10/hot-investor-mandate-usa-based-vc-firm-invests-up-to-10m-in-companies-developing-medical-devices-diagnostics-and-research-tools/2024-12-10T17:25:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/10/hot-investor-mandate-vc-firm-invests-in-seed-to-series-a-companies-in-medtech-healthtech-and-techbio-sectors-with-usa-focus/2024-12-10T17:25:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/10/innovators-pitch-challenge-winning-companies-at-resi-london/2024-12-10T13:32:30+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/03/navigating-early-stage-funding-in-life-sciences/2024-12-10T13:32:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/12/03/resi-jpm-2025-ipc-finalists/https://blog.lifesciencenation.com/wp-content/uploads/2024/12/jpm-ipc-for-np.jpgJPM-IPC-for-NP2024-12-03T14:53:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/19/confirmed-investors-at-resi-london-and-resi-jpm/https://blog.lifesciencenation.com/wp-content/uploads/2024/11/resi-jpm-ci11192024.jpgRESI-JPM-CI11192024https://blog.lifesciencenation.com/wp-content/uploads/2024/11/resi-london-ci11192024.jpgRESI-London-CI111920242024-11-19T16:35:57+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/19/resi-jpm-expands-virtual-partnering-to-meet-attendee-needs/2024-11-19T16:33:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/19/dennis-ford-the-ceo-of-life-science-nation-on-global-fundraising/https://blog.lifesciencenation.com/wp-content/uploads/2024/11/podcast-global-fundraising-in-life-sciences.jpgpodcast-Global-Fundraising-in-Life-Sciences2024-11-19T16:33:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/get-in-the-groove-and-tune-up-your-pitch-at-two-groundbreaking-resi-events-from-life-science-nation/2024-11-13T18:42:57+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/resi-london-innovators-pitch-challenge-finalists/https://blog.lifesciencenation.com/wp-content/uploads/2024/11/resi-london-ipc-finalists.jpgRESI-London-IPC-Finalists2024-11-13T17:46:50+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/upcoming-investor-fireside-chat-webinar-exploring-early-stage-investment-opportunities-with-insights-from-resi-conferences/https://blog.lifesciencenation.com/wp-content/uploads/2024/11/investor-fireside-chat-1.jpgInvestor Fireside Chat2024-11-13T17:44:50+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/hot-investor-profile-global-life-sciences-provider-invests-and-partners-with-technology-enabled-platform-companies/2024-11-13T17:34:23+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/hot-investor-profile-pharma-corporate-venture-arm-seeks-to-invest-in-therapeutics-platform-technology-companies-in-the-us-and-europe/2024-11-13T17:34:21+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/hot-investor-profile-vc-firm-looks-to-invest-in-pre-seed-to-series-a-companies-working-on-digital-health-technologies-focusing-on-north-america/2024-11-13T17:34:19+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/13/hot-investor-profile-vc-firm-formed-by-medical-device-experts-seek-to-invest-in-early-stage-medtech-companies-interested-in-china-market-entry/2024-11-13T17:34:17+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/unlock-investor-connections-resi-london-and-resi-jpm-partnering-opens-november-18/2024-11-05T18:01:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/hot-investor-profile-single-family-office-actively-involved-in-cross-border-investments-into-healthcare-companies-leveraging-technology/2024-11-05T17:55:28+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/hot-investor-profile-usa-based-vc-firm-seeks-biotech-therapeutics-companies-investing-up-to-15m-over-the-companys-lifecycle/2024-11-05T17:55:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/hot-investor-profile-family-office-backed-vc-fund-invests-broadly-across-all-life-sciences-sectors-seeking-seed-to-pre-series-a-companies-across-the-globe/2024-11-05T17:55:23+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/hot-investor-profile-vc-firm-seeks-usa-based-startups-in-medical-devices-diagnostics-and-digital-health-sectors-addressing-unmet-medical-need/2024-11-05T17:55:22+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/maximize-your-reach-with-life-science-innovators-exhibit-at-resi-jpm/2024-11-05T17:37:29+00:00monthlyhttps://blog.lifesciencenation.com/2024/11/05/first-place-insights-diana-caldwell-on-amplified-sciences-and-the-resi-boston-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2024/11/diana.jpgDiana2024-11-05T17:37:23+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/extended-pitch-time-resis-innovators-pitch-challenge-gets-an-upgrade/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/ipc-article-image.jpgIPC-Article-Image2024-10-29T15:59:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/resi-london-2024-a-truly-global-gathering-of-life-science-investors/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/resi-london-ci.jpgRESI-London-CI2024-10-29T15:43:19+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/innovating-together-insights-from-biojapan-2024-with-life-science-nation/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/biojp.jpgBiojphttps://blog.lifesciencenation.com/wp-content/uploads/2024/10/biojp2.jpgBiojp22024-10-29T15:31:00+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/hot-investor-profile-corporate-venture-fund-invests-in-early-stage-first-in-class-therapeutics-and-innovative-platform-technologies-focusing-on-companies-in-us-and-europe/2024-10-29T15:29:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/hot-investor-profile-vc-firm-seeks-to-fund-innovative-therapeutics-devices-and-diagnostics-in-ophthalmology-across-north-america-and-europe/2024-10-29T15:29:37+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/hot-investor-profile-usa-based-vc-firm-seeks-to-invest-in-seed-to-series-b-life-science-companies-with-a-focus-on-therapeutics-and-medical-devices/2024-10-29T15:29:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/29/hot-investor-profile-vc-firm-invests-in-usa-based-seed-stage-companies-in-the-fields-of-digital-health-and-ai-enabled-healthcare-technologies/2024-10-29T15:29:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/how-to-succeed-in-company-presentations-pitches-as-conferences-the-drive-to-win-and-what-it-takes/2024-10-23T13:33:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/conversation-with-john-qiao-founder-ceo-of-radioclash-innovators-pitch-challenge-success-at-resi-boston/2024-10-22T15:15:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/advameds-the-medtech-conference-we-came-we-saw-we-connected/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/medtech-photo.jpgMedTech Photo2024-10-22T15:15:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/hot-investor-profile-global-vc-firm-invests-in-all-life-science-healthcare-sectors-typically-seeking-opportunities-from-series-a/2024-10-22T12:56:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/hot-investor-profile-europe-based-vc-firm-invests-in-highly-scalable-high-growth-potential-healthtech-companies-based-in-europe/2024-10-22T12:56:13+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/hot-investor-profile-usa-based-vc-firm-invests-in-seed-to-series-a-diagnostics-companies-across-the-globe/2024-10-22T12:56:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/22/hot-investor-profile-active-angel-group-invests-in-all-technology-and-life-science-sectors-from-seed-to-early-venture-stage-usa-based-companies/2024-10-22T12:56:10+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/resi-london-connecting-global-life-science-startups-with-investors/2024-10-16T15:44:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/eywa-biotech-pioneering-psychedelic-apis-for-mental-health-treatment/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/victoria-paz.jpgVictoria-Paz2024-10-16T13:06:31+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/prepare-for-resi-london-and-resi-jpm-with-free-webinars-on-fundraising-and-partnering/2024-10-16T13:06:29+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/hot-investor-profile-large-corporation-with-life-science-focused-venture-arm-invests-in-therapeutics-diagnostics-and-digital-health-companies-with-middle-east-market-potential/2024-10-16T13:04:43+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/hot-investor-profile-pharma-corporate-venture-arm-invests-in-therapeutics-and-digital-technologies-with-strong-interests-in-platform-technologies/2024-10-16T13:04:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/hot-investor-profile-newly-established-vc-firm-seeks-seed-stage-companies-in-ai-synthetic-biology-cell-gene-therapy-companies-in-the-us/2024-10-16T13:04:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/16/hot-investor-profile-europe-based-vc-firm-invests-in-pre-seed-and-seed-stage-ai-driven-life-science-and-healthcare-companies-across-the-globe/2024-10-16T13:04:37+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/hot-investor-profile-global-pe-and-vc-firm-with-uk-us-offices-invests-across-early-to-late-stage-approaching-ipo-in-therapeutics-healthcare-medtech-opportunities/2024-10-08T15:12:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/hot-investor-profile-corporate-vc-arm-of-global-dairy-corporation-seeks-seed-to-series-a-biotech-innovations-for-human-health-open-to-various-deal-structures/2024-10-08T15:12:34+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/hot-investor-profile-global-pe-firm-with-uk-and-us-offices-seeking-10m-to-30m-private-market-opportunities-in-therapeutics-medical-devices-and-diagnostics/2024-10-08T15:12:25+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/hot-investor-profile-boston-based-stage-agnostic-boutique-vc-investing-in-healthcare-focused-on-longevity-and-aging-related-technologies/2024-10-08T15:10:24+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/jpm-101/2024-10-08T15:01:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/unlocking-global-fundraising-opportunities-with-resi-from-london-to-jpm-2025/2024-10-08T13:28:57+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/08/life-science-nation-expands-global-reach-at-biojapan-2024-and-the-medtech-conference/2024-10-08T13:28:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/01/resi-boston-2024-record-breaking-partnering-and-fundraising-opportunities/2024-10-01T18:25:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/01/resi-boston-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2024/10/ipc-judge-picks.jpgIPC-Judge-Pickshttps://blog.lifesciencenation.com/wp-content/uploads/2024/10/resi-boston-3rd-place.jpgRESI-Boston-3rd-Placehttps://blog.lifesciencenation.com/wp-content/uploads/2024/10/resi-boston-2nd-place.jpgRESI-Boston-2nd-Placehttps://blog.lifesciencenation.com/wp-content/uploads/2024/10/resi-boston-1st-place.jpgRESI-Boston-1st-Place2024-10-01T16:03:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/10/01/event-landing-your-company-in-the-boston-life-sciences-ecosystem/2024-10-01T16:03:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/19/last-chance-to-register-for-resi-boston-virtual-and-in-person-options-available/https://blog.lifesciencenation.com/wp-content/uploads/2024/09/ci09192024.jpgCI091920242024-09-19T12:49:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/19/unlock-global-investor-networks-at-resi-london-and-resi-jpm/https://blog.lifesciencenation.com/wp-content/uploads/2024/09/genesis-banner-with-resi-2024-600px-wide.pngGenesis-banner-with-Resi-2024-600px-widehttps://blog.lifesciencenation.com/wp-content/uploads/2024/09/resi-boston-2024-september-with-on-1100px.jpgRESI-Boston-2024-September-with-ON---1100px2024-09-19T12:46:56+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/19/talon-biomarkers-role-in-precision-drug-development/https://blog.lifesciencenation.com/wp-content/uploads/2024/09/pratip-chattopadhyay.jpgPratip-Chattopadhyay2024-09-19T12:46:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/interview-with-dr-gennady-bratslavsky-avicella-capital-on-resi-experience-from-an-investors-point-of-view/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/dr.-gennady-bratslavsky.jpgDr.-Gennady-Bratslavsky2024-09-16T17:04:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/12/resi-boston-2024-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2024/09/digital-resi-boston-2024-program-guide-cover.jpg[Digital]-RESI-Boston-2024-Program-Guide-Cover2024-09-12T15:59:48+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/12/introducing-ipc-judges-at-resi-boston-2024/2024-09-12T15:58:48+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/meet-the-investors-engage-with-industry-leaders-at-resi-boston-2024/2024-09-05T16:53:24+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/exploring-family-office-investment-strategies/2024-09-05T16:52:10+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/elevate-your-pitch-at-resi-a-unique-opportunity/2024-09-05T16:52:08+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/hot-investor-profile-vc-pe-firm-specialized-in-life-sciences-invests-10-40m-in-venture-and-growth-stage-therapeutics-and-medical-device-companies/2024-09-05T16:51:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/hot-investor-profile-vc-firm-with-family-office-ties-seeks-early-stage-therapeutics-companies-based-in-usa-and-europe/2024-09-05T16:51:09+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/hot-investor-profile-europe-based-vc-firm-invests-in-pre-seed-and-seed-stage-healthtech-companies-with-strong-data-or-computing-component/2024-09-05T16:51:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/09/05/hot-investor-profile-vc-firm-looks-for-innovative-digital-health-technologies-with-high-potential-in-us-markets-investing-up-to-15m/2024-09-05T16:51:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/innovating-for-a-cure-insights-from-mdas-leaders-on-the-future-of-dmd-research/2024-08-29T18:45:19+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/the-resi-boston-innovators-pitch-challenge-finalists-announced/2024-08-29T16:54:14+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/navigating-diagnostics-investment-at-resi-boston/2024-08-29T16:54:08+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/hot-investor-profile-life-science-focused-vc-seeks-innovative-early-and-mid-stage-therapeutics-companies-in-europe-investing-up-to-e20m/2024-08-29T16:52:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/hot-investor-profile-life-science-healthcare-focused-vc-invests-across-all-life-science-sectors-especially-medical-devices-with-a-focus-on-us/2024-08-29T16:52:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/hot-investor-profile-vc-firm-actively-invests-in-early-stage-therapeutics-companies-across-all-modalities-and-indications-across-the-globe/2024-08-29T16:52:31+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/29/hot-investor-profile-usa-based-vc-seeks-pre-seed-and-seed-stage-investment-opportunities-in-all-life-science-and-healthcare-sectors/2024-08-29T16:52:30+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/mastering-the-art-of-fundraising-essential-strategies-for-startups/2024-08-22T20:55:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/the-boston-cambridge-life-science-ecosystem-your-gateway-to-success/2024-08-22T18:41:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/partnering-with-pharma-panel-at-resi-boston-a-gateway-for-startups/2024-08-22T16:38:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/hot-investor-profile-taiwan-vc-seeks-to-invest-up-to-10m-in-pre-series-a-to-series-b-companies-in-intersection-of-technology-and-life-sciences/2024-08-22T16:33:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/hot-investor-profile-europe-based-life-sciences-vc-invests-up-to-e10m-in-therapeutics-and-medical-device-companies-in-north-america-and-europe/2024-08-22T16:33:44+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/hot-investor-profile-us-and-asia-based-vc-firm-with-us-and-asia-offices-seeks-to-invest-in-seed-to-series-a-companies-across-all-healthcare-sectors/2024-08-22T16:33:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/22/hot-investor-profile-vc-firm-with-offices-in-us-and-europe-actively-invests-in-innovative-drug-development-companies-across-all-therapeutic-areas/2024-08-22T16:33:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/family-office-perspectives-on-early-stage-investments/https://blog.lifesciencenation.com/wp-content/uploads/2024/08/picture3.pngPicture3https://blog.lifesciencenation.com/wp-content/uploads/2024/08/chart-1-fo.jpgChart-1-FO2024-08-15T17:21:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/why-life-science-ceos-should-seize-the-opportunity-at-redefining-early-stage-investments-resi-events/2024-08-15T15:51:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/partnering-opportunities-at-resi-boston-platform-opens-august-19/2024-08-15T15:36:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/hot-investor-profile-new-venture-fund-invests-in-early-stage-therapeutics-companies-in-north-america-europe-and-israel/2024-08-15T15:34:34+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/hot-investor-profile-corporate-venture-fund-of-large-pharmaceutical-seeks-global-opportunities-in-therapeutics-and-platform-technologies/2024-08-15T15:34:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/hot-investor-profile-europe-based-vc-firm-with-new-fund-invests-in-digital-health-ai-enabled-medtech-and-other-digital-technologies/2024-08-15T15:33:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/15/hot-investor-profile-impact-driven-venture-fund-invests-in-pre-seed-to-series-a-digital-health-software-startups-across-europe/2024-08-15T15:33:25+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/unlocking-early-stage-investment-opportunities/https://blog.lifesciencenation.com/wp-content/uploads/2024/08/jill-goldstein.jpgJill-Goldsteinhttps://blog.lifesciencenation.com/wp-content/uploads/2024/08/allan-gobbs.jpgAllan-Gobbshttps://blog.lifesciencenation.com/wp-content/uploads/2024/08/chris-garabedian.jpgChris-Garabedianhttps://blog.lifesciencenation.com/wp-content/uploads/2024/08/ashim_subedee.pngAshim_Subedeehttps://blog.lifesciencenation.com/wp-content/uploads/2024/08/squire-servance.jpgSquire-Servance2024-08-09T14:05:24+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/family-office-bioforum-at-resi-boston-sept-25-family-office-fund-managers-deliver-keynotes/2024-08-08T16:41:20+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/innovations-in-neuromuscular-disease/https://blog.lifesciencenation.com/wp-content/uploads/2024/08/sharon-hesterlee.jpgSharon-Hesterlee2024-08-08T16:38:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/hot-investor-profile-us-subsidiary-of-global-corporation-seeks-strategic-investments-and-partnerships-with-medical-device-diagnostics-and-digital-health-companies/2024-08-08T16:36:20+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/hot-investor-profile-newly-established-corporate-vc-fund-invests-in-early-stage-diagnostics-digital-health-and-life-science-tools-companies/2024-08-08T16:36:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/hot-investor-profile-usa-based-vc-firm-invests-in-therapeutics-and-diagnostics-companies-located-outside-large-innovation-hubs/2024-08-08T16:36:16+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/08/hot-investor-profile-vc-fund-invests-in-therapeutics-companies-in-cns-oncology-chronic-diseases-rare-disease-and-more-across-the-globe/2024-08-08T16:36:14+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/01/hot-investor-profile-cvc-of-japanese-large-pharma-makes-equity-investments-in-innovative-therapeutics-and-drug-discovery-platforms-in-usa-and-europe/2024-08-01T16:00:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/01/hot-investor-profile-newly-established-vc-invests-globally-in-medtech-and-digital-health-companies-and-is-open-to-considering-companies-in-pre-prototype-stage/2024-08-01T16:00:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/01/hot-investor-profile-us-based-biotech-focused-vc-seeks-to-invests-up-to-15m-in-therapeutics-companies-of-all-stages-with-particular-interest-in-oncology-immunology-cns-and-more/2024-08-01T16:00:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/01/hot-investor-profile-life-science-social-impact-vc-in-nyc-zurich-invests-in-series-a-and-later-opportunities-with-indications-in-public-global-health-including-infectious-diseases/2024-08-01T15:59:59+00:00monthlyhttps://blog.lifesciencenation.com/2024/08/01/one-nucleus-and-life-science-nation-unite-for-the-genesis-2024-and-redefining-early-stage-investments-resi-conferences-to-amplify-impact-on-life-science-innovation/https://blog.lifesciencenation.com/wp-content/uploads/2024/07/resi-london-2024-1100px.jpgRESI-London-2024-1100px2024-08-01T13:18:57+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/31/breaking-barriers-in-science-the-journey-of-meritxell-teixido-and-gate2brain/https://blog.lifesciencenation.com/wp-content/uploads/2024/07/meritxell-teixido.jpgMeritxell-Teixidó2024-08-01T13:18:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/24/resi-boston-2024-empowering-early-stage-life-science-innovation-through-tech-hub-collaboration/2024-08-01T13:18:50+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/24/from-biochemist-to-biotech-pioneer/https://blog.lifesciencenation.com/wp-content/uploads/2024/07/sunil_shah.jpgSunil_Shah2024-07-30T17:26:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/25/what-would-a-harris-administration-mean-for-biotech-investment/2024-07-25T16:46:10+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/25/hot-investor-profile-usa-based-single-family-office-seeks-to-invest-in-pre-seed-and-seed-stage-therapeutics-addressing-cns-and-oncology-indications/2024-07-25T16:44:44+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/25/hot-investor-profile-europe-based-vc-seeks-to-invest-in-pre-clinical-therapeutics-companies-in-oncology-immunology-rare-diseases-and-more/2024-07-25T16:44:43+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/25/hot-investor-profile-us-based-vc-invests-in-pre-seed-and-seed-companies-across-medtech-and-digital-health-sectors/2024-07-25T16:44:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/25/hot-investor-profile-global-pharmaceutical-looks-for-early-stage-strategic-partnerships-with-therapeutic-programs-in-dermatology/2024-07-25T16:44:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/24/revolutionizing-rehabilitation-dycares-silvia-raga-on-rehubs-impact-and-future-ambitions/https://blog.lifesciencenation.com/wp-content/uploads/2024/07/silvia-raga.jpgSilvia-Raga2024-07-25T14:52:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/sponsorship-opportunities-for-resi-boston-2024-and-resi-jpm-2025-connecting-early-stage-life-science-innovators-with-global-investors-and-strategic-partners/2024-07-18T17:47:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/navigating-the-treacherous-waters-of-life-science-startups-insights-into-raising-capital/2024-07-18T17:47:09+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/resi-jpm-2025-moves-to-san-francisco-marriott-marquis-expanding-opportunities-for-life-science-networking/2024-07-18T17:47:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/hot-investor-profile-venture-arm-of-hospital-system-seeks-to-make-strategic-investments-in-early-stage-digital-health-companies/2024-07-18T16:49:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/hot-investor-profile-vc-firm-managing-multi-billion-aum-invests-in-life-science-and-healthcare-technologies-across-the-globe/2024-07-18T16:49:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/hot-investor-profile-investor-group-invests-in-usa-based-software-enabled-devices-digital-health-and-healthcare-services-with-demonstrated-early-traction/2024-07-18T16:45:08+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/hot-investor-profile-canada-based-vc-invests-in-pre-seed-and-seed-stage-companies-across-the-globe-in-all-areas-of-life-sciences-healthcare/2024-07-18T16:44:48+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/18/resi-jpm-location-update-for-2025/2024-07-18T13:02:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/hot-investor-profile-usa-based-vc-firm-engages-in-series-a-and-b-financings-in-medical-devices-diagnostics-and-digital-health-sectors/2024-07-11T14:29:28+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/hot-investor-profile-transatlantic-venture-fund-invests-in-us-and-europe-based-therapeutics-medical-device-companies/2024-07-11T14:29:24+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/hot-investor-profile-usa-based-vc-invests-up-to-10m-in-devices-advanced-materials-platform-technologies-and-more-across-the-globe/2024-07-11T14:29:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/hot-investor-profile-leading-china-based-pharma-company-seeks-pre-clinical-and-early-clinical-assets-in-cns-oncology-metabolic-diseases-and-more/2024-07-11T14:28:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/announcing-resi-boston-investor-panel-lineup/2024-07-11T14:22:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/07/11/free-webinars-in-preparation-for-a-successful-resi-boston/2024-07-11T14:21:53+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/27/innovators-pitch-challenge-winners-at-resi-europe/https://blog.lifesciencenation.com/wp-content/uploads/2024/06/shared-image.jpgshared imagehttps://blog.lifesciencenation.com/wp-content/uploads/2024/06/dsc09509.jpgDSC09509https://blog.lifesciencenation.com/wp-content/uploads/2024/06/dsc09515.jpgDSC095152024-07-05T19:54:29+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/27/hot-investor-profile-corporate-venture-fund-focuses-on-investments-in-therapeutics-diagnostics-companies-targeting-rare-and-orphan-diseases/2024-06-27T17:29:20+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/27/hot-investor-profile-usa-based-vc-firm-seeks-to-invest-up-to-15m-in-life-science-companies-with-a-strong-focus-on-therapeutics-companies/2024-06-27T17:29:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/27/hot-investor-profile-vc-firm-invests-in-biotech-companies-in-early-clinical-stage-of-development-open-to-global-opportunities/2024-06-27T17:29:16+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/27/hot-investor-profile-vc-firm-with-usa-china-offices-invests-in-all-sectors-of-life-sciences-and-healthcare-and-supports-asia-market-entry/2024-06-27T17:29:13+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/13/investor-panelists-at-resi-europe/https://blog.lifesciencenation.com/wp-content/uploads/2024/06/speakers.jpgSpeakers2024-06-13T13:35:56+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/13/investor-fireside-chat/2024-06-13T13:31:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/13/biocat-lunch-keynote-at-resi-europe-2024/2024-06-13T13:31:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/hot-investor-profile-corporate-venture-arm-of-global-japan-corporation-seeking-early-stage-therapeutic-technologies-especially-platform-technologies/2024-06-06T16:27:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/hot-investor-profile-spanish-pharmaceutical-company-opens-to-different-partnership-structures-seeking-preclinical-to-phase-i-drug-discovery-innovations-globally/2024-06-06T16:27:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/hot-investor-profile-norway-based-vc-launching-life-science-and-medicine-dedicated-fund-interested-in-seed-to-series-a-therapeutics-opportunities/2024-06-06T16:27:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/hot-investor-profile-us-based-vc-focused-on-neuroscience-related-technologies-seeking-seed-to-series-b-opportunities-globally/2024-06-06T16:27:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/fundraising-is-a-numbers-game-so-why-are-many-startups-not-playing/2024-06-06T16:24:16+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/brazilian-biotech-innovators-prep-for-global-stage/2024-06-06T16:24:08+00:00monthlyhttps://blog.lifesciencenation.com/2024/06/06/resi-europe-program-guide-released/2024-06-06T15:58:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/resi-europe-innovators-pitch-challenge-finalists-announced-2/https://blog.lifesciencenation.com/wp-content/uploads/2024/05/resi-europe-ipc-finalist.jpgRESI-Europe-IPC-Finalist2024-05-30T16:22:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/introducing-the-digital-health-panel-at-resi-europe/2024-05-30T16:22:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/life-science-partnering-conferences-evaluating-the-roi/2024-05-30T16:22:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/hot-investor-profile-family-office-with-accelerator-arm-invests-up-to-10m-in-early-clinical-stage-therapeutics-with-strong-interest-in-biologics/2024-05-30T16:21:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/hot-investor-profile-usa-based-vc-firm-seeks-therapeutics-and-digital-health-companies-with-validated-proof-of-concept-across-the-globe/2024-05-30T16:21:31+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/hot-investor-profile-vc-firm-invests-up-to-30m-with-opportunistic-mandate-across-all-life-science-and-healthcare-sectors-including-platform-technologies/2024-05-30T16:21:30+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/30/hot-investor-profile-usa-based-vc-firm-invests-in-pre-seed-to-series-a-life-science-healthtech-companies-with-inaugural-fund/2024-05-30T16:21:28+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/partnering-for-resi-europe-launches-next-week/2024-05-23T22:29:29+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/announcing-resi-europes-seed-fund-panel-lineup/2024-05-23T16:35:54+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/investment-eligibility-what-does-a-startup-need/2024-05-23T16:35:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/hot-investor-profile-venture-arm-of-global-insurance-company-seeks-medtech-and-digital-health-companies-in-us-europe-and-china-investing-5-10m/2024-05-23T16:34:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/hot-investor-profile-global-investment-firm-has-opportunistic-mandate-investing-in-all-life-science-sectors-with-high-potential-from-seed-to-ipo-stage/2024-05-23T16:34:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/hot-investor-profile-usa-based-vc-firm-seeks-innovative-medical-devices-diagnostics-and-all-technologies-in-the-intersection-of-data-and-life-sciences/2024-05-23T16:34:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/23/hot-investor-profile-europe-based-alternative-asset-manager-invests-e1-5m-in-pre-clinical-therapeutics-and-revenue-positive-medtech-digital-health-companies/2024-05-23T16:34:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/watch-investor-panel-provide-insights-on-sourcing-vetting-startups-for-resi-europe/2024-05-16T16:53:16+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/resi-europe-early-bird-rates-end-tomorrow/2024-05-16T16:32:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/resi-europe-calling-for-global-tech-hubs-incubators-accelerators-universities-and-more/2024-05-16T16:32:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/hot-investor-profile-europe-vc-part-of-a-large-investment-holding-company-seeks-disruptive-therapeutics-companies-investing-up-to-e10m/2024-05-16T15:49:48+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/hot-investor-profile-china-based-pe-firm-invests-5-10m-in-therapeutics-devices-and-diagnostics-companies-with-usd-and-rmb-funds/2024-05-16T15:49:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/hot-investor-profile-corporate-venture-arm-of-large-corporate-with-evergreen-fund-invests-in-therapeutics-devices-and-digital-health-across-the-globe/2024-05-16T15:49:44+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/16/hot-investor-profile-vc-seeks-new-early-and-growth-stage-opportunities-in-therapeutics-digital-health-life-science-tools-in-north-america-europe/2024-05-16T15:49:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/100-investor-meetings-in-6-months/2024-05-09T15:56:01+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/connecting-early-stage-life-science-companies-with-investors-at-resi-europe-2024/2024-05-09T15:42:06+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/the-key-to-sinon-nano-sciences-success-in-the-resi-south-innovators-pitch-challenge/https://blog.lifesciencenation.com/wp-content/uploads/2024/05/laura-gunter.jpgLaura-Gunterhttps://blog.lifesciencenation.com/wp-content/uploads/2024/05/afreen-allam.jpgAfreen-Allam2024-05-09T15:42:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/hot-investor-profile-asia-based-pe-firm-invests-up-to-10m-open-to-innovative-companies-in-all-life-science-sectors/2024-05-09T15:01:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/hot-investor-profile-investment-firm-in-the-us-seeks-to-invest-in-digital-health-companies-focusing-on-series-a-financings/2024-05-09T15:01:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/hot-investor-profile-usa-vc-firm-invests-in-pre-seed-and-seed-stage-healthcare-companies-leveraging-ai/2024-05-09T15:01:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/09/hot-investor-profile-seed-fund-looks-for-us-and-canada-based-companies-in-precision-medicine-neuro-longevity-and-more/2024-05-09T15:01:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/life-science-nation-offers-tools-to-prepare-global-partnering-campaigns-2/2024-05-02T16:21:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/guaranteed-investor-audience-for-early-stage-innovators-at-resi-pitch-competition/2024-05-02T16:20:26+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/hot-investor-profile-pharma-company-with-us-and-china-offices-seeks-early-and-late-clinical-stage-assets-in-pediatrics-respiratory-oncology-and-more/2024-05-02T14:35:53+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/hot-investor-profile-usa-based-family-office-looks-for-medical-devices-diagnostics-digital-health-companies-close-to-exit/2024-05-02T14:35:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/hot-investor-profile-impact-venture-fund-invests-in-solutions-targeting-the-aging-population-focused-on-europe-based-companies/2024-05-02T14:35:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/hot-investor-profile-corporate-vc-seeks-digital-health-and-regenerative-medicine-companies-across-the-globe/2024-05-02T14:35:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/05/02/webinar-series-empowering-early-stage-life-science-entrepreneurs/2024-05-02T14:29:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/29/confirmed-early-stage-investors-attending-resi-europe-in-june-2/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/resi-europe-confirmed-investors-4292024.jpgRESI-Europe-Confirmed-Investors-42920242024-04-29T20:50:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/29/life-science-nation-offers-tools-to-prepare-global-partnering-campaigns/2024-04-29T20:09:09+00:00monthlyhttps://blog.lifesciencenation.com/tech-hub-monthly/2024-04-29T16:21:33+00:00weekly0.6https://blog.lifesciencenation.com/2024/04/25/what-makes-resi-europe-stand-out/2024-04-25T16:06:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/exhibit-at-resi-europe/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/dsc9738-scaled-1.jpgDSC9738-scaledhttps://blog.lifesciencenation.com/wp-content/uploads/2024/04/20240325_103412.jpg20240325_103412https://blog.lifesciencenation.com/wp-content/uploads/2024/04/dsc1819.jpgDSC18192024-04-25T15:39:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/ipc-winner-sanguina-finds-connection-at-resi-south/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/maria-thacker-goethe.jpgMaria Thacker-Goethehttps://blog.lifesciencenation.com/wp-content/uploads/2024/04/erika-tyburski.jpgErika Tyburski2024-04-25T15:39:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/hot-investor-mandate-usa-based-firm-invests-in-therapeutics-medical-devices-and-diagnostics-companies-in-us-europe-israel-with-inaugural-life-sciences-fund/2024-04-25T15:37:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/hot-investor-mandate-corporate-venture-fund-seeks-biotech-investment-opportunities-in-the-us-china-and-europe-from-seed-stage-to-ipo/2024-04-25T15:37:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/hot-investor-mandate-vc-firm-invests-in-seed-to-series-b-life-science-technologies-addressing-underserved-populations-and-geographies-in-the-us/2024-04-25T15:37:00+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/25/hot-investor-mandate-europe-based-vc-looks-to-invest-in-pre-seed-to-series-a-rounds-for-pre-clinical-stage-drug-development-companies/2024-04-25T15:36:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/decoding-the-mysteries-behind-the-low-success-rate-of-life-science-startups/2024-04-18T18:31:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/confirmed-early-stage-investors-attending-resi-europe-in-june/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/ci04182024.jpgCI041820242024-04-18T15:47:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/closing-the-funding-gap-in-europe/2024-04-18T15:45:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/hot-investor-mandate-vc-with-us-china-offices-invests-up-to-8m-in-early-stage-therapeutics-devices-diagnostics-in-us-and-europe/2024-04-18T15:43:16+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/hot-investor-mandate-europe-based-pe-firm-looks-for-therapeutics-and-medical-device-companies-globally-investing-e1-20m-in-mostly-companies-based-in-europe/2024-04-18T15:43:15+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/hot-investor-mandate-vc-firm-invests-in-and-builds-companies-in-healthtech-and-tech-enabled-health-services-seeking-technologies-in-usa-canada/2024-04-18T15:43:02+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/18/hot-investor-mandate-global-investment-firm-seeks-novel-medical-device-opportunities-with-strong-interest-in-pma-devices-across-all-subsectors-indications/2024-04-18T15:42:59+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/liquet-medical-has-first-time-resi-success/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/john-newby.jpgJohn-Newbyhttps://blog.lifesciencenation.com/wp-content/uploads/2024/04/john-newby-vabio.jpgJohn-Newby-Vabio2024-04-11T18:54:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/announcing-resi-europe-panel-lineup/2024-04-11T15:43:23+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/tech-hubs-at-resi-europe/2024-04-11T15:43:13+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/hot-investor-mandate-usa-based-single-family-office-invests-in-therapeutics-medical-device-and-diagnostics-companies-in-north-america/2024-04-11T15:40:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/hot-investor-mandate-china-based-investment-firm-invests-in-therapeutics-diagnostics-companies-in-the-usa-with-dedicated-fund/2024-04-11T15:40:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/hot-investor-mandate-vc-with-us-europe-offices-invests-up-to-15m-in-rd-enabling-technologies-considering-global-opportunities/2024-04-11T15:40:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/11/hot-investor-mandate-vc-firm-seeks-series-a-b-financing-opportunities-in-medical-devices-diagnostics-and-digital-health-investing-up-to-e8m/2024-04-11T15:40:27+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/redefining-early-stage-investment-resi-is-returning-to-europe/2024-04-07T13:21:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/congratulations-to-the-resi-south-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/1st-place.jpg1st-placehttps://blog.lifesciencenation.com/wp-content/uploads/2024/04/2nd-place.jpg2nd-placehttps://blog.lifesciencenation.com/wp-content/uploads/2024/04/3rd-place.jpg3rd-place2024-04-04T15:55:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/upcoming-sponsorship-opportunities-for-resi-europe-resi-boston/https://blog.lifesciencenation.com/wp-content/uploads/2024/04/resi-boston-2024-september-1100pxw.jpgRESI-Boston-2024-September-1100pxw2024-04-04T15:55:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/hot-investor-mandate-venture-arm-of-global-pharmaceutical-seeks-innovative-therapeutics-companies-in-oncology-neurology-and-rare-diseases/2024-04-04T15:52:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/hot-investor-mandate-angel-investment-group-invests-in-life-science-companies-looking-to-expand-into-the-china-market-focusing-on-medtech-companies/2024-04-04T15:51:58+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/hot-investor-mandate-impact-investor-interested-in-investing-in-global-life-science-technologies-focused-on-pediatric-indications/2024-04-04T15:51:53+00:00monthlyhttps://blog.lifesciencenation.com/2024/04/04/hot-investor-mandate-vc-invests-in-pre-seed-and-seed-stage-cns-therapeutics-and-neurotech-companies-based-in-the-us/2024-04-04T15:51:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/workshops-at-resi-south/2024-03-21T15:57:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/resi-south-ipc-finalists/2024-03-21T15:53:56+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/hear-from-investors-attending-resi-south/2024-03-21T15:53:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/lsic-x-lsn-joint-webinar-for-japanese-life-science-community/2024-03-21T15:53:47+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/hot-investor-mandate-cvc-fund-invests-in-medtech-digital-health-technologies-that-address-chronic-conditions-and-areas-of-unmet-medical-need/2024-03-21T15:50:42+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/hot-investor-mandate-venture-fund-seeks-pre-seed-to-series-a-investments-in-usa-based-therapeutics-diagnostics-and-data-driven-companies/2024-03-21T15:50:40+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/hot-investor-mandate-taiwan-vc-invests-up-to-10m-in-technology-based-companies-addressing-chronic-disease-management-oncology-metabolic-diseases-and-more/2024-03-21T15:50:38+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/21/hot-investor-mandate-vc-headquartered-in-china-invests-5-10m-focusing-on-seed-stage-therapeutics-and-growth-stage-diagnostics-across-the-globe/2024-03-21T15:50:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/14/presenting-the-resi-south-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2024/03/resi-south-cover.jpgRESI-South-Cover2024-03-15T21:09:48+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/14/hot-investor-mandate-usa-based-vc-invests-10-40m-in-novel-therapeutics-companies-across-all-modalities-and-indications/2024-03-14T15:37:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/14/hot-investor-mandate-multi-faceted-ibank-invests-in-seed-to-series-a-stage-life-science-companies-capable-of-investing-10m/2024-03-14T15:37:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/14/hot-investor-mandate-fund-and-venture-builder-invests-in-global-medtech-companies-advancing-the-field-of-neurotechnology/2024-03-14T15:37:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/14/hot-investor-mandate-large-biopharmaceutical-seeks-in-licensing-opportunities-in-oncology-and-immunology-across-the-globe/2024-03-14T15:37:02+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/announcing-the-speaker-lineup-at-resi-south/2024-03-07T21:00:35+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/what-makes-resi-stand-out/2024-03-07T18:17:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/tips-for-successful-partnering-at-resi-south/2024-03-07T18:14:02+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/hot-investor-mandate-vc-in-western-europe-invests-up-to-e20m-in-us-europe-based-devices-diagnostics-and-digital-health-companies/2024-03-07T18:09:58+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/hot-investor-mandate-investment-arm-of-international-cdmo-invests-in-early-stage-pre-ind-cell-gene-therapy-companies-across-the-globe/2024-03-07T18:09:54+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/hot-investor-mandate-us-based-investment-firm-seeks-life-science-technologies-in-areas-of-neurology-ophthalmology-pulmonology/2024-03-07T18:09:50+00:00monthlyhttps://blog.lifesciencenation.com/2024/03/07/hot-investor-mandate-vc-firm-invests-up-to-10m-in-early-stage-technologies-relevant-to-precision-personalized-medicine-based-in-us-canada/2024-03-07T18:09:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/new-resi-location-brings-new-investors-attending/2024-02-29T18:02:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/tagline-competition-winners/2024-02-29T16:41:22+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/resi-south-partnering-opens-next-monday/2024-02-29T16:37:45+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/hot-investor-mandate-global-manufacturing-company-with-newly-established-cvc-invests-in-clinical-stage-devices-diagnostics-biomanufacturing-and-more/2024-02-29T16:35:56+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/hot-investor-mandate-vc-firm-invests-in-usa-based-medical-device-diagnostics-companies-with-validated-poc/2024-02-29T16:35:54+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/hot-investor-mandate-venture-fund-seeks-healthcare-technology-companies-targeting-the-us-market-from-pre-seed-to-series-a-rounds/2024-02-29T16:35:52+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/29/hot-investor-mandate-vc-with-us-china-offices-looks-for-novel-therapeutics-medtech-digital-health-capable-of-investing-over-10m/2024-02-29T16:35:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/27/how-to-meet-alabama-life-sci-startups-at-resi-south/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/logo-png_dark-colors-2.pngLogo PNG_dark colors (2)https://blog.lifesciencenation.com/wp-content/uploads/2024/02/synvivo-logo-final-new.pngSynVivo-Logo-Final-NEWhttps://blog.lifesciencenation.com/wp-content/uploads/2024/02/horizontalgreenresb.pngHorizontalGreenResBhttps://blog.lifesciencenation.com/wp-content/uploads/2024/02/gs-f-logo_horizontal-royalbg-1.jpgGS, F, Logo_Horizontal, RoyalBG (1)https://blog.lifesciencenation.com/wp-content/uploads/2024/02/bio-alabama-logo-1.pngBIO Alabama Logo (1)2024-02-27T17:45:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/the-art-of-raising-money-for-a-life-sciences-company/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/kenny-headshot.jpgKenny-Headshothttps://blog.lifesciencenation.com/wp-content/uploads/2023/02/podcast-image.jpgPodcast-image2024-02-27T14:38:14+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/21/the-art-of-raising-money-for-a-life-sciences-company-3/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/untitled-8.jpgUntitled-82024-02-27T14:38:09+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/hot-investor-mandate-vc-firm-invests-5-10m-in-early-stage-drug-discovery-companies-across-the-globe-open-to-all-modalities-and-indications/2024-02-22T17:34:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/hot-investor-mandate-canada-based-firm-invests-in-seed-to-series-b-digital-health-technologies-and-medtech-companies-with-digital-component/2024-02-22T17:34:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/hot-investor-mandate-life-sciences-healthcare-focused-vc-invests-in-seed-stage-companies-in-devices-diagnostics-and-digital-health/2024-02-22T17:33:59+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/hot-investor-mandate-asia-headquartered-investment-firm-seeks-global-opportunities-in-ai-empowered-solutions-devices-and-more-addressing-chronic-disease-management/2024-02-22T17:33:54+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/the-case-for-life-science-service-providers-at-resi-partnering-events/2024-02-22T16:53:30+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/resi-south-early-bird-rates-end-tomorrow/2024-02-22T14:55:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/22/the-right-resi-south-registration-for-you/2024-02-22T14:55:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/share-your-standout-tagline-for-a-shot-at-winning-resi-south-tickets-dont-miss-out/https://blog.lifesciencenation.com/wp-content/uploads/2024/01/submit_your_tagline.pngSubmit_Your_Tagline2024-02-15T18:45:09+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/investors-and-licensing-partners-voting-with-their-feet-making-the-case-for-resi-south/2024-02-15T18:30:57+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/the-value-of-the-resi-innovators-pitch-challenge-ipc/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/david-medina.jpgDavid Medinahttps://blog.lifesciencenation.com/wp-content/uploads/2024/02/alberto-ramos-vernieri.jpgAlberto Ramos Vernierihttps://blog.lifesciencenation.com/wp-content/uploads/2024/02/vanessa-williamson.jpgVanessa Williamson2024-02-15T17:17:04+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/introducing-panelists-on-the-seed-funds-panel-at-resi-south/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/screenshot-2024-02-15-112159.pngScreenshot 2024-02-15 1121592024-02-15T17:16:54+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/hot-investor-mandate-family-office-backed-investment-fund-seeks-life-science-healthcare-companies-in-australia-and-beyond/2024-02-15T17:14:14+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/hot-investor-mandate-us-europe-based-investment-group-allocates-up-to-60m-in-therapeutics-devices-and-diagnostics-companies-from-early-clinical-stage/2024-02-15T17:14:11+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/hot-investor-mandate-family-office-invests-in-technologies-addressing-cns-diseases-and-disorders-seeking-global-opportunities/2024-02-15T17:14:10+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/15/hot-investor-mandate-angel-group-seeks-early-stage-investments-in-medtech-and-digital-health-in-cardiology-neurology-and-more/2024-02-15T17:14:08+00:00monthlyhttps://blog.lifesciencenation.com/next-phase-2011-2023-backup/2024-02-09T13:37:25+00:00weekly0.6https://blog.lifesciencenation.com/previous-issues-next-phase-2016-2018/2024-02-09T13:36:22+00:00weekly0.6https://blog.lifesciencenation.com/previous-issues-next-phase-2019-2021/2024-02-09T13:34:53+00:00weekly0.6https://blog.lifesciencenation.com/previous-issues-next-phase-2011-2015/2024-02-09T13:31:23+00:00weekly0.6https://blog.lifesciencenation.com/previous-issues-next-phase-2022-2023/2024-02-09T13:29:00+00:00weekly0.6https://blog.lifesciencenation.com/2024/02/08/investors-at-resi-south-2024/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/faith.jpgFaithhttps://blog.lifesciencenation.com/wp-content/uploads/2024/02/ci-02082024.jpgCI-020820242024-02-08T17:39:07+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/resi-south-calling-for-global-tech-hubs-incubators-accelerators-universities-and-more/https://blog.lifesciencenation.com/wp-content/uploads/2024/02/cth-02082024.jpgCTH-020820242024-02-08T17:02:13+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/lsn-navigating-the-path-to-commercialization/2024-02-08T17:01:44+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/hot-investor-mandate-china-based-pharmaceutical-with-dedicated-corporate-venture-arm-seeks-investment-partnership-opportunities-in-novel-therapeutic-assets/2024-02-08T16:58:55+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/hot-investor-mandate-vc-firm-focuses-investments-on-oncology-therapeutics-in-the-us-and-western-europe-with-interest-in-platform-technologies/2024-02-08T16:58:51+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/hot-investor-mandate-investment-arm-of-healthcare-system-invests-in-series-a-and-b-rounds-in-healthcare-solutions-addressing-unmet-medical-need/2024-02-08T16:58:46+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/08/hot-investor-mandate-corporate-investment-arm-invests-in-global-life-science-companies-most-interested-in-ai-based-diagnostics-and-genomics/2024-02-08T16:58:41+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/preparing-and-executing-a-global-fundraising-campaign-8003-rule/2024-02-01T18:27:58+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/lsn-offers-free-webinars-in-preparation-for-a-successful-resi-south/2024-02-01T15:54:12+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/hot-investor-mandate-family-run-investment-vehicle-invests-in-early-stage-therapeutics-companies-with-a-strong-focus-on-rare-disease-assets/2024-02-01T15:53:36+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/hot-investor-mandate-global-life-science-tools-manufacturer-partners-and-invests-in-tools-lab-equipment-ai-leveraging-companies-in-north-america-europe/2024-02-01T15:53:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/hot-investor-mandate-usa-based-vc-invests-in-therapeutics-devices-and-digital-health-wellness-companies-targeting-cns-mental-behavioral-diseases-and-more/2024-02-01T15:53:32+00:00monthlyhttps://blog.lifesciencenation.com/2024/02/01/hot-investor-mandate-biotech-focused-fund-invests-actively-in-therapeutics-and-digital-health-technologies-interested-in-expanding-to-japanese-market/2024-02-01T15:53:29+00:00monthlyhttps://blog.lifesciencenation.com/2022/04/26/lsn-conducts-entrepreneurial-master-class-workshop-for-100-fulbright-foreign-students/https://blog.lifesciencenation.com/wp-content/uploads/2022/02/img_5788.jpegIMG_5788https://blog.lifesciencenation.com/wp-content/uploads/2022/02/20220421_175135.jpg20220421_175135https://blog.lifesciencenation.com/wp-content/uploads/2022/02/img_5772.jpegIMG_57722024-01-29T22:05:49+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/26/tagline-competition-and-innovators-pitch-challenge-applications-open-for-resi-south/2024-01-29T16:02:58+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/29/how-do-accelerators-incubators-universities-and-more-collaborate-with-life-science-nation-and-resi-conferences/2024-01-29T15:59:18+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/resi-south-2024-innovators-pitch-challenge-ipc-application-is-now-open/2024-01-25T16:33:05+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/introducing-investor-panels-for-resi-south-march-2024/2024-01-25T16:33:00+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/hot-investor-mandate-vc-firm-with-us-china-operations-invests-in-early-and-growth-stage-novel-therapeutics-companies-globally/2024-01-25T16:31:28+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/hot-investor-mandate-healthcare-vc-invest-up-to-15m-in-all-areas-of-life-sciences-and-healthcare-preferring-to-see-early-clinical-data/2024-01-25T16:30:39+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/hot-investor-mandate-western-europe-based-firm-invests-globally-in-life-sciences-healthcare-companies-with-inaugural-fund/2024-01-25T16:30:37+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/25/hot-investor-mandate-4-new-usa-based-fund-invests-in-seed-stage-digital-health-companies-targeting-oncology/2024-01-25T16:30:33+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/you-are-invited-to-join-lsn-in-atlanta-georgia-for-resi-south-and-barcelona-spain-for-resi-europe/https://blog.lifesciencenation.com/wp-content/uploads/2024/01/resi-spain-1100.jpgRESI-SPAIN-11002024-01-18T16:30:09+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/congratulations-to-the-resi-jpm-innovators-pitch-challenge-winners/https://blog.lifesciencenation.com/wp-content/uploads/2024/01/dsc1604.jpg_DSC1604https://blog.lifesciencenation.com/wp-content/uploads/2024/01/dsc1602.jpg_DSC1602https://blog.lifesciencenation.com/wp-content/uploads/2024/01/dsc1608.jpg_DSC16082024-01-18T16:09:28+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/resi-jpm-recap-record-investor-registrations-and-3000-connections-made/2024-01-18T16:09:20+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/hot-investor-mandate-usa-based-vc-invests-in-global-companies-addressing-mental-behavioral-health/2024-01-18T16:08:06+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/hot-investor-mandate-corporate-venture-arm-of-global-crdmo-seeks-biotech-investment-opportunities-in-us-china-and-europe/2024-01-18T16:08:03+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/hot-investor-mandate-venture-fund-invests-in-510k-and-pma-medical-devices-addressing-cardiology-neurology-and-surgery/2024-01-18T16:08:02+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/18/hot-investor-mandate-venture-arm-of-innovation-hub-leads-pre-seed-and-seed-rounds-for-life-science-and-healthcare-startups-in-the-us/2024-01-18T16:07:58+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/04/resi-jpm-2024-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2024/01/resi-jpm-pg-cover.jpgRESI-JPM-PG-Cover2024-01-05T13:59:37+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/27/life-science-nation-announces-the-redefining-early-stage-investments-resi-for-2024-and-you-are-all-invited-2/2024-01-05T13:37:37+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/04/life-science-nation-announces-the-redefining-early-stage-investments-resi-for-2024-and-you-are-all-invited/2024-01-04T16:49:53+00:00monthlyhttps://blog.lifesciencenation.com/2024/01/04/corval-returns-to-resi/https://blog.lifesciencenation.com/wp-content/uploads/2024/01/susan-nemetz.jpgSusan-Nemetz2024-01-04T16:49:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/hot-investor-mandate-corporate-venture-arm-of-manufacturing-company-seeks-to-invest-in-clinical-diagnostics-and-medical-device-companies/2023-12-28T18:24:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/hot-investor-mandate-vc-firm-invests-in-ai-enabled-healthcare-companies-in-seed-to-series-b-rounds-with-focus-in-us-canada-and-uk/2023-12-28T18:22:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/hot-investor-mandate-usa-based-investment-group-invests-1-5m-in-innovative-medical-device-and-diagnostics-companies/2023-12-28T18:19:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/hot-investor-mandate-norway-based-coalition-invests-up-to-100m-usd-in-biotech-companies-targeting-infectious-diseases-with-focus-on-global-south/2023-12-28T18:17:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/interview-with-dennis-ford-founder-of-life-science-nation-regarding-the-resi-jpm-partnering-conference-january-9-11-2024/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/grge.jpegGRGE2023-12-28T18:13:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/28/companies-to-watch-in-2024/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/indiebio-2.jpgindiebio (2)https://blog.lifesciencenation.com/wp-content/uploads/2023/12/revbio-.jpegRevBiohttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/convergence-medical-.jpegConvergence Medicalhttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/biomark-oncology.jpegBioMark Oncologyhttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/prapela.pngPrapelahttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/brainstorm-therapeutics-.jpegBrainStorm Therapeuticshttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/thrive-bioscience.jpegThrive-Biosciencehttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/cardathea-inc.jpegCardathea-Inchttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/cari-healthe280af-.jpgCari Health https://blog.lifesciencenation.com/wp-content/uploads/2023/12/ternalys-therapeutics-.jpegTernalys Therapeutics2023-12-28T17:57:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/27/tips-for-a-successful-jpm-healthcare-week-2024/2023-12-28T15:11:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/27/the-right-resi-jpm-registration-for-you/2023-12-27T20:11:22+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/nih-leads-the-way-in-life-science-innovation/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/nih-banner.jpgNIH-Banner2023-12-21T15:18:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/three-new-early-stage-investors-attending-resi-jpm-for-first-time/2023-12-21T15:17:30+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/introducing-ipc-judges-at-resi-jpm-2024/2023-12-21T15:06:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/hot-investor-mandate-usa-based-vc-invests-up-to-40m-in-clinical-stage-therapeutics-in-oncology-rare-diseases-and-more-with-focus-on-us-and-europe/2023-12-21T14:35:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/hot-investor-mandate-ivd-company-strategically-invests-and-partners-with-diagnostics-and-digital-healthcare-companies-across-the-globe/2023-12-21T14:35:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/hot-investor-mandate-vc-firm-invests-in-usa-based-digital-health-and-tech-enabled-healthcare-services-companies-in-venture-and-growth-stage/2023-12-21T14:34:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/21/hot-investor-mandate-single-family-office-invests-in-seed-to-series-c-medical-device-companies-with-strong-interest-in-surgical-solutions/2023-12-21T14:34:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/27/tech-hubs-at-resi-tech-hub-opportunities/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/indiebio.jpgindiebiohttps://blog.lifesciencenation.com/wp-content/uploads/2023/12/efl.jpegeflhttps://blog.lifesciencenation.com/wp-content/uploads/2023/11/obi-1.jpgobi-1https://blog.lifesciencenation.com/wp-content/uploads/2023/11/obi.jpgobihttps://blog.lifesciencenation.com/wp-content/uploads/2023/11/medstartr-ventures-3-2.jpgmedstartr-ventures-3-2https://blog.lifesciencenation.com/wp-content/uploads/2023/11/medstartr-ventures-4-1.jpgmedstartr-ventures-4-1https://blog.lifesciencenation.com/wp-content/uploads/2023/11/medstartr-ventures-4.jpgmedstartr-ventures-4https://blog.lifesciencenation.com/wp-content/uploads/2023/11/medstartr-ventures-3-1.jpgmedstartr-ventures-3-1https://blog.lifesciencenation.com/wp-content/uploads/2023/11/image.pngimagehttps://blog.lifesciencenation.com/wp-content/uploads/2023/11/ganesha-lab-.jpegganesha-lab-2023-12-18T20:52:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/announcing-speaker-lineup-at-resi-jpm-2024/2023-12-14T18:00:14+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/maximizing-success-in-partnering-conferences-strategic-metrics-and-conference-navigation/2023-12-14T17:57:49+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/resi-jpm-a-global-gathering/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/greg-2.jpgGreg-2https://blog.lifesciencenation.com/wp-content/uploads/2023/12/greg-1.jpgGreg-12023-12-14T17:57:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/hot-investor-mandate-1-single-family-office-fund-invests-up-to-10m-in-early-stage-and-30m-in-later-stage-device-diagnostics-companies-globally/2023-12-14T17:56:10+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/hot-investor-mandate-vc-firm-invests-in-us-and-japan-based-companies-in-all-life-science-sectors-with-strong-interest-in-age-related-diseases/2023-12-14T17:56:06+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/hot-investor-mandate-investment-firm-in-the-uk-invests-in-diagnostics-digital-health-companies-across-the-globe-usually-in-pre-seed-to-series-a-rounds/2023-12-14T17:56:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/14/hot-investor-mandate-early-stage-vc-invests-1-2m-in-innovative-life-science-companies-especially-platform-and-cross-disciplinary-technologies/2023-12-14T17:55:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/life-science-nation-biocat-and-biotechgate-announce-resi-europe-barcelona-2024-june-17th-in-person-18th-19th-virtual-2/2023-12-07T17:46:20+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/the-right-messaging-for-partnering-success/https://blog.lifesciencenation.com/wp-content/uploads/2023/12/resi-sf-2024-banner-1100px-new.jpgRESI-SF-2024-Banner-1100px new2023-12-07T17:46:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/check-out-the-companies-pitching-at-resi-jpm-2024/2023-12-07T17:45:39+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/announcing-global-family-office-bioforum-at-resi-jpm-michael-langer-to-give-keynote-at-luncheon-january-9th-2024/2023-12-07T17:43:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/hot-investor-mandate-usa-based-vc-focuses-on-investing-in-companies-addressing-cns-diseases-and-mental-behavioral-healt/2023-12-07T17:10:29+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/hot-investor-mandate-pe-firm-with-us-offices-invests-20-50m-in-companies-in-at-least-early-clinical-stage-focusing-on-companies-based-in-north-america/2023-12-07T17:09:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/hot-investor-mandate-corporate-vc-arm-of-pharmaceutical-invests-up-to-20m-in-therapeutics-and-rd-companies-also-involved-in-licensing-and-joint-ventures/2023-12-07T17:09:05+00:00monthlyhttps://blog.lifesciencenation.com/2023/12/07/hot-investor-mandate-investment-group-of-medical-device-experts-looks-to-invest-in-and-grow-devices-diagnostics-companies-with-strong-china-angle/2023-12-07T17:09:03+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/life-science-nation-biocat-and-biotechgate-announce-resi-europe-barcelona-2024-june-17th-in-person-18th-19th-virtual/2023-12-07T15:55:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/michael-langer-former-pear-therapeutics-executive-and-family-office-entrepreneur-discusses-startup-investing-in-the-life-science-domain/2023-11-30T21:01:46+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/save-the-date-lsns-first-resi-in-atlanta-march-2024/2023-11-30T17:26:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/partnering-for-resi-jpm-2024-launches-monday-december-4/2023-11-30T17:22:30+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/hot-investor-mandate-cross-border-life-sciences-vc-invests-up-to-30m-in-life-science-companies-based-in-us-europe-and-asia/2023-11-30T17:08:38+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/hot-investor-mandate-asia-headquartered-biotech-seeks-investment-and-in-licensing-opportunities-with-early-stage-therapeutics-companies-investing-up-to-10m/2023-11-30T17:08:36+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/hot-investor-mandate-usa-investment-firm-looks-for-medical-device-diagnostics-and-digital-health-companies-in-north-america-investing-in-series-a-and-b-rounds/2023-11-30T17:08:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/30/hot-investor-mandate-corporate-venture-arm-of-pharmaceutical-seeks-to-invest-and-partner-with-novel-platform-technologies-in-cns-immunology-and-more/2023-11-30T17:08:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/21/life-science-nation-announces-resi-south-march-2024/2023-11-27T22:02:10+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/22/lsn-tagline-contest-winners-announced-the-power-of-precision-having-a-clear-and-concise-tagline-not-a-slogan/https://blog.lifesciencenation.com/wp-content/uploads/2023/11/tagline.jpgtagline2023-11-22T17:39:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/save-300-and-meet-500-investors-at-resi-jpm-early-bird-rates-end-tomorrow/2023-11-16T17:02:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/lsns-asia-roadshow-part-1-entrepreneurial-educational-bootcamps-in-hong-kong-and-singapore/https://blog.lifesciencenation.com/wp-content/uploads/2023/11/20231019_103429000_ios.jpg20231019_103429000_iOS2023-11-16T16:41:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/gliachems-innovators-pitch-challenge-success-at-resi/https://blog.lifesciencenation.com/wp-content/uploads/2023/11/vanessa-williamson.jpgVanessa-Williamson2023-11-16T16:25:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/hot-investor-mandate-life-sciences-focused-venture-fund-invests-up-to-25m-in-therapeutics-targeting-oncology-metabolic-disorders-and-more-with-china-market-potential/2023-11-16T16:25:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/hot-investor-mandate-western-europe-based-firm-invests-broadly-across-all-life-science-sectors-preferring-to-engage-in-pre-seed-to-series-a-rounds/2023-11-16T16:25:00+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/hot-investor-mandate-vc-firm-invests-in-north-america-based-deeptech-companies-including-healthcare-companies-addressing-the-aging-and-chronic-diseases-market/2023-11-16T16:24:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/16/hot-investor-mandate-government-backed-firm-seeks-investment-and-partnership-opportunities-with-global-prototype-ready-medical-device-companies/2023-11-16T16:24:54+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/have-a-great-tagline-submit-and-win-resi-jpm-tickets/https://blog.lifesciencenation.com/wp-content/uploads/2023/11/submit-your-tagline.pngSubmit Your Tagline2023-11-09T17:21:36+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/crafting-an-effective-ip-strategy-guiding-capital-investors-and-licensing-partners-toward-your-innovation/2023-11-09T17:21:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/life-science-nation-announces-free-webinar-series-in-preparation-for-resi-jpm/2023-11-09T17:21:28+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/hot-investor-mandate-europe-based-venture-capital-firm-with-multiple-funds-under-management-invests-across-healthcare-sectors-including-digital-health-diagnostics-medical-devices-and-more-in-the-u/2023-11-09T17:20:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/hot-investor-mandate-hong-kong-life-science-venture-capital-firm-seeks-therapeutics-and-medical-devices-opportunities-globally-with-focuses-on-oncology-immunology-metabolic-and-cns-diseases/2023-11-09T17:20:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/hot-investor-mandate-new-york-based-venture-capital-firm-invests-in-series-a-and-beyond-looking-for-healthcare-services-digital-health-and-medical-devices-companies-that-targets-unmet-needs-or-unde/2023-11-09T17:20:46+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/09/hot-investor-mandate-us-private-investment-firm-invests-in-digital-health-and-medical-technologies-with-software-component-prefers-founding-team-with-both-technical-and-business-expertise/2023-11-09T17:20:44+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/medical-device-panel-at-resi-jpm-2024/https://blog.lifesciencenation.com/wp-content/uploads/2023/11/final-medical-devices-panel-jpm24.jpgFinal - Medical Devices Panel JPM242023-11-02T16:23:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/important-deadlines-are-approaching/2023-11-02T16:21:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/resi-2024-series-media-partnership-opportunities/2023-11-02T16:00:25+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/hot-investor-mandate-vc-firm-in-japan-invests-up-to-10m-in-early-stage-life-science-companies-across-the-globe-open-to-all-therapeutic-modalities/2023-11-02T15:58:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/hot-investor-mandate-corporate-venture-arm-of-major-corporation-invests-in-therapeutics-digital-health-and-ai-applications-through-multiple-funds/2023-11-02T15:58:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/hot-investor-mandate-vc-invests-in-series-a-and-b-rounds-in-life-science-technologies-with-opportunistic-mandate-focusing-on-usa-based-companies/2023-11-02T15:58:15+00:00monthlyhttps://blog.lifesciencenation.com/2023/11/02/hot-investor-mandate-usa-vc-firm-focuses-on-investing-in-early-stage-consumer-facing-digital-health-technologies-in-seed-to-series-b-rounds/2023-11-02T15:58:11+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/10-tips-to-speed-up-your-fundraising-journey-at-a-resi-partnering-event/2023-10-26T15:11:30+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/the-crucial-role-of-a-dedicated-meeting-coordinator-in-the-startup-fundraising-process/2023-10-26T15:04:11+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/global-partnering-campaign-lsn-investor-and-licensing-partner-database/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/watch-demo-video.pngWatch Demo Video2023-10-26T15:04:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/hot-investor-mandate-life-science-investment-firm-invests-exclusively-in-seed-to-series-b-therapeutics-companies-typically-investing-around-10m/2023-10-26T15:02:37+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/hot-investor-mandate-china-based-vc-with-multi-billion-aum-seeks-new-breakthrough-technologies-in-all-life-science-sectors-including-drug-discovery-enabling-technologies/2023-10-26T15:02:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/hot-investor-mandate-healthcare-vc-invests-in-medtech-and-digital-health-investing-up-to-8m-in-series-a-to-c-rounds-open-to-global-companies/2023-10-26T15:02:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/26/hot-investor-mandate-usa-based-family-office-seeks-early-stage-digital-health-companies-investing-in-fields-including-health-analytics-precision-medicine-and-more/2023-10-26T15:02:29+00:00monthlyhttps://blog.lifesciencenation.com/2022/12/15/crafting-the-perfect-message-2/2023-10-26T14:57:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/23/attitude-and-execution-combine-to-be-a-self-fulfilling-prophecy-2/2023-10-23T14:49:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/light-line-medical-wins-the-innovators-pitch-challenge-and-looks-toward-their-series-b-raise/2023-10-19T15:50:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/confirmed-early-stage-investors-at-resi-jpm/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/confirmed-investors-10172023.jpgConfirmed-Investors-101720232023-10-19T15:48:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/announcing-se-lifesci-investor-coalition-as-title-sponsor-at-resi-jpm-2024/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/se-life-sci.jpgSE-Life-Sci2023-10-19T15:41:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/hot-investor-mandate-family-office-invests-in-life-science-companies-preferring-to-invest-in-therapeutics-companies-based-in-europe-with-global-outlook/2023-10-19T15:39:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/hot-investor-mandate-firm-backed-by-multiple-health-systems-seeks-to-fund-medtech-digital-health-and-healthcare-services-companies-in-the-usa/2023-10-19T15:38:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/hot-investor-mandate-europe-based-vc-invests-up-to-e25m-in-biotech-medtech-and-enabling-tech-companies-opportunistic-in-specific-areas-of-interest/2023-10-19T15:38:57+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/19/hot-investor-mandate-vc-with-usa-operations-invests-1-5m-in-companies-in-the-intersection-of-biology-and-technology-including-synthetic-biology/2023-10-19T15:38:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/life-science-nation-will-assess-and-help-determine-how-prepared-you-are-to-fundraise/2023-10-12T17:24:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/lsn-heading-to-hong-kong-singapore-rising-healthcare-and-life-science-hotspots-in-asia/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/lsi-lsn-programme-flyer-with-qr-code-002.jpgLSI-LSN Programme Flyer with QR Code (002)https://blog.lifesciencenation.com/wp-content/uploads/2023/10/hkstp-bootcamp-1.pngHKSTP Bootcamp (1)2023-10-12T16:26:20+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/life-science-nation-and-california-life-science-join-force-again-in-resi-jpm-2024/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/resi-sf-2024-banner-1100.pngRESI-SF-2024-Banner-1100https://blog.lifesciencenation.com/wp-content/uploads/2023/10/cls-interview.jpgCLS interview2023-10-12T16:25:46+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/hot-investor-mandate-japan-based-corporate-venture-capital-of-an-oncology-focused-pharmaceutical-company-seeks-early-stage-drug-discovery-technologies-globallyhot-investor-mandate/2023-10-12T15:54:20+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/hot-investor-mandate-venture-capital-established-by-us-hospital-network-focuses-on-digital-health-medical-devices-healthcare-technology-systems-and-services-with-strategic-alignments/2023-10-12T15:52:03+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/hot-investor-mandate-us-based-venture-capital-invests-pre-seed-to-series-a-in-early-stage-novel-technologies-across-all-life-science-sectors/2023-10-12T15:51:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/12/hot-investor-mandate-us-based-seed-stage-investor-focuses-on-digital-health-services-healthcare-it-with-working-prototypes-and-more/2023-10-12T15:51:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/06/global-roadshow-information-and-preparation-2/2023-10-06T14:59:11+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/hot-investor-mandate-private-investment-firm-invests-1-5m-in-disruptive-medical-device-technologies-targeting-sizable-markets/2023-10-06T12:56:37+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/hot-investor-mandate-early-stage-venture-fund-focuses-investments-on-novel-therapeutic-approaches-including-cell-gene-therapy/2023-10-06T12:56:31+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/hot-investor-mandate-usa-based-vc-invests-up-to-10m-in-series-a-and-b-stage-medical-device-diagnostics-and-digital-health-companies-on-a-global-scale/2023-10-06T12:56:25+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/hot-investor-mandate-seed-early-venture-stage-firm-invests-broadly-in-all-technologies-relating-to-reproductive-and-maternal-health/2023-10-06T12:56:19+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/unlocking-strategic-investor-connections-through-our-investor-database/2023-10-05T16:26:13+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/introducing-the-resi-jpm-2024-investor-panels/https://blog.lifesciencenation.com/wp-content/uploads/2023/10/resi-jpm-ipc.jpgRESI-JPM-IPC2023-10-05T15:17:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/10/05/collaborate-with-us-explore-sponsorship-and-media-partnership-opportunities-in-2024/2023-10-05T15:15:31+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/once-a-year-opportunity-for-medtech-digital-health-investors-companies/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/raymond-ray-briscuso.jpgRaymond-“Ray”-Briscusohttps://blog.lifesciencenation.com/wp-content/uploads/2023/09/mtc23-email-header-graphic_medtech-2.jpgMTC23-Email-Header-Graphic_MedTech-22023-09-28T15:48:00+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/identify-the-right-resi-registration-for-your-stage-of-fundraising/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/registration-type-chart.jpgRegistration-Type-Chart2023-09-28T15:36:49+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/the-redefining-early-stage-investments-resi-jpm-2024-innovators-pitch-challenge-ipc-application-is-now-open/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/dsc9986.jpg_DSC9986https://blog.lifesciencenation.com/wp-content/uploads/2023/09/dsc0160.jpg_DSC01602023-09-28T15:15:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/hot-investor-mandate-life-science-focused-vc-invests-up-to-e50m-in-pre-clinical-clinical-stage-drug-development-companies-in-north-america-and-europe/2023-09-28T15:14:28+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/hot-investor-mandate-venture-arm-of-healthcare-services-company-invests-strategically-in-new-care-models-clinical-services-oncology-and-more/2023-09-28T15:14:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/hot-investor-mandate-investment-firm-focuses-investments-on-pre-seed-and-seed-stage-deeptech-companies-including-digital-health-and-medtech-companies-with-ai-component/2023-09-28T15:14:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/28/hot-investor-mandate-usa-based-vc-firm-seeks-to-invest-in-seed-to-series-b-companies-that-target-better-care-delivery-and-diagnosis-ai-driven-drug-discovery-and-more/2023-09-28T15:14:23+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/21/congratulations-to-the-resi-boston-september-2023-pitch-winners/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/resi-jpm-2024.jpgRESI-JPM-2024https://blog.lifesciencenation.com/wp-content/uploads/2023/09/dsc0232.jpg_DSC0232https://blog.lifesciencenation.com/wp-content/uploads/2023/09/dsc0241.jpg_DSC0241https://blog.lifesciencenation.com/wp-content/uploads/2023/09/dsc0243.jpg_DSC02432023-09-21T15:27:12+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/life-science-nation-big4bio-present-lifesci-startup-a-daily-newsletter/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/free-aap-pass.pngFREE AAP Passhttps://blog.lifesciencenation.com/wp-content/uploads/2023/08/lss-template.jpgLSS-template2023-09-20T17:42:38+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/meet-the-judges-of-the-resi-boston-septembers-innovators-pitch-challenge-ipc-next-week/2023-09-14T21:40:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/crossing-the-atlantic-european-startups-finding-funding-at-resi/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/podcast-cover-greg.jpgPodcast Cover Greg2023-09-14T16:15:12+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/interview-with-martin-gershon-managing-partner-and-cio-at-endeavor-venture-fund-venture-studio/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/martin-gershon.jpgMartin-Gershon2023-09-14T16:11:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/hot-investor-mandate-cro-turned-healthcare-vc-invests-15-20m-in-promising-therapeutics-and-medtech-companies-in-early-clinical-stage/2023-09-14T15:58:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/hot-investor-mandate-usa-china-based-vc-invests-broadly-in-all-life-science-sectors-with-strong-interest-in-cvd-oncology-and-womens-health/2023-09-14T15:58:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/hot-investor-mandate-usa-based-investment-firm-pursues-technology-based-seed-to-series-c-life-science-healthcare-companies/2023-09-14T15:58:54+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/14/hot-investor-mandate-vc-firm-invests-up-to-20m-novel-therapeutics-and-medical-devices-with-a-strong-focus-on-usa-based-companies/2023-09-14T15:58:47+00:00monthlyhttps://blog.lifesciencenation.com/subscribe/2023-09-14T12:32:17+00:00weekly0.6https://blog.lifesciencenation.com/2023/09/07/presenting-the-resi-boston-september-2023-program-guide/https://blog.lifesciencenation.com/wp-content/uploads/2023/09/podcast-with-lsn-log.jpgPodcast-with-LSN-loghttps://blog.lifesciencenation.com/wp-content/uploads/2023/09/resi-boston-september-2023-program-guide_cover.jpgRESI-Boston-September-2023-Program-Guide_Cover2023-09-07T15:30:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/07/hot-investor-mandate-usa-based-vc-invests-up-to-10m-over-companys-lifecycle-in-life-science-companies-preferring-early-clinical-stage-opportunities/2023-09-07T15:02:23+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/07/hot-investor-mandate-vc-firm-with-inaugural-fund-seeks-therapeutics-companies-in-oncology-cns-rare-diseases-and-more-with-a-focus-in-western-europe/2023-09-07T15:02:21+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/07/hot-investor-mandate-investment-firm-focuses-on-investing-in-medical-devices-diagnostics-and-digital-health-companies-from-seed-to-series-a-across-the-globe/2023-09-07T15:02:19+00:00monthlyhttps://blog.lifesciencenation.com/2023/09/07/hot-investor-mandate-growth-equity-fund-invests-20-60m-in-revenue-generating-healthcare-companies-in-north-america/2023-09-07T15:02:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/announcing-investor-panelists-at-resi-boston-september-2023/2023-08-31T16:21:28+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/introducing-corval-a-new-sponsor-to-the-resi-conference-series/2023-08-31T16:21:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/hot-investor-mandate-usa-based-family-office-invests-across-all-life-science-sectors-most-interested-in-clinical-stage-companies-capable-of-investing-up-to-100m/2023-08-31T16:16:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/hot-investor-mandate-investment-firm-allocates-up-to-15m-in-global-life-science-opportunities-with-a-focus-on-us-and-china-based-opportunities/2023-08-31T16:16:31+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/hot-investor-mandate-vc-firm-with-uk-and-usa-offices-seeks-life-science-technologies-with-digital-component-investing-up-to-10m/2023-08-31T16:16:29+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/31/hot-investor-mandate-usa-based-vc-invests-in-seed-stage-healthcare-it-and-ai-based-life-sciences-companies-prefers-to-lead-rounds/2023-08-31T16:16:28+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/28/resi-partnering-is-open-all-tech-hub-affiliates-get-discounted-rates/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/untitled-design-9.jpgUntitled design (9)https://blog.lifesciencenation.com/wp-content/uploads/2023/08/untitled-design-10.jpgUntitled design (10)2023-08-28T19:01:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/muneer-satter-family-office-investor-philanthropist-global-rights-activist-to-keynote-resi-family-office-bioforum/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/global-family-office-bioforum.jpgGlobal-Family-Office-BioForumhttps://blog.lifesciencenation.com/wp-content/uploads/2023/08/muneer-satter.jpgMuneer-Satter2023-08-24T16:59:52+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/view-the-50-companies-pitching-at-resi-boston-september-2023/2023-08-24T16:16:10+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/explore-nih-funding-opportunities-at-resi-boston-conference/2023-08-24T15:30:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/hot-investor-mandate-life-science-vc-with-strong-china-market-expertise-seeks-novel-therapeutics-across-all-modalities-from-seed-to-growth-stage/2023-08-24T15:30:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/hot-investor-mandate-usa-based-vc-invests-in-cancer-focused-digital-health-technologies-typically-investing-in-seed-opportunities/2023-08-24T15:30:06+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/hot-investor-mandate-european-investment-firm-seeks-innovative-therapeutics-opportunities-investing-up-to-e20m-over-the-companys-lifecycle/2023-08-24T15:30:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/24/hot-investor-mandate-family-office-fund-invests-in-north-american-companies-in-the-intersection-of-technology-of-life-science-such-as-ai-enabled-drug-discovery-platforms/2023-08-24T15:30:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/resi-september-features-family-office-bioforum/2023-08-17T17:11:17+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/partnering-opens-for-resi-boston-next-week/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/premier-mandates.jpgPremier-Mandateshttps://blog.lifesciencenation.com/wp-content/uploads/2023/08/partnering_tutorial_webinar.jpgPartnering_Tutorial_Webinar2023-08-17T16:40:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/lsn-announces-collaboration-with-government-of-ontario-and-ontario-bioscience-innovation-organization-obio-at-resi-boston-in-september/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/ontario-companies.jpgOntario Companies2023-08-17T15:52:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/hot-investor-mandate-usa-based-investment-firm-makes-both-venture-growth-stage-investments-focusing-exclusively-on-therapeutics/2023-08-17T15:50:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/hot-investor-mandate-early-stage-venture-fund-managed-by-top-vc-firms-seeks-novel-disruptive-medtech-and-digital-health-companies-in-usa-europe/2023-08-17T15:50:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/hot-investor-mandate-usa-based-vc-actively-invests-in-novel-therapeutic-assets-starting-from-late-pre-clinical-stage-opportunistic-towards-indication/2023-08-17T15:50:37+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/17/hot-investor-mandate-growth-equity-firm-invests-up-to-100m-in-life-science-healthcare-companies-close-to-commercialization/2023-08-17T15:50:36+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/surge-in-family-offices-investing-in-healthcare/2023-08-10T16:00:17+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/announcing-the-global-partnering-campaign-lsns-newest-product/2023-08-10T15:52:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/interview-with-shikha-sharma-senior-director-innovation-at-california-life-sciences-cls/https://blog.lifesciencenation.com/wp-content/uploads/2023/08/susan-nemetz.jpgSusan-Nemetzhttps://blog.lifesciencenation.com/wp-content/uploads/2023/08/shikha-sharma.jpgShikha-Sharma2023-08-10T15:50:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/hot-investor-mandate-usa-based-multi-family-office-invests-in-seed-to-series-a-life-science-companies-with-strong-interests-in-oncology/2023-08-10T15:49:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/hot-investor-mandate-vc-firm-with-us-europe-offices-invests-with-a-new-fund-in-early-stage-life-sciences-with-opportunistic-mandate/2023-08-10T15:49:25+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/hot-investor-mandate-china-based-global-pharmaceutical-seeks-innovative-drug-candidates-for-strategic-partnership-in-oncology-cns-autoimmune-disease-and-more/2023-08-10T15:49:23+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/10/hot-investor-mandate-usa-based-vc-fund-seeks-new-opportunities-in-digital-health-software-and-tech-enabled-healthcare-services/2023-08-10T15:49:21+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/apply-before-august-9-and-join-these-confirmed-companies-at-resi-september-innovators-pitch-challenge-ipc/2023-08-03T16:05:03+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/exhibiting-at-resi-boston-september-2023/2023-08-03T15:33:22+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/enhancing-efficiency-and-strategy-of-investor-outreach/2023-08-03T15:33:17+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/hot-investor-mandate-taiwan-vc-invests-in-biomaterials-medical-device-and-digital-health-companies-open-to-cross-border-investment-opportunities/2023-08-03T15:32:10+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/hot-investor-mandate-multi-family-office-fund-seeks-new-opportunities-in-medtech-and-lab-equipment-focusing-on-the-western-us/2023-08-03T15:32:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/hot-investor-mandate-family-office-backed-vc-firm-invests-in-healthcare-technologies-with-strong-interest-in-mental-behavioral-health/2023-08-03T15:32:06+00:00monthlyhttps://blog.lifesciencenation.com/2023/08/03/hot-investor-mandate-large-manufacturer-actively-seeks-strategic-partnerships-with-therapeutics-companies-including-platform-technologies-in-cvd-metabolic-disease-and-more/2023-08-03T15:32:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/confirmed-attendees-for-resi-boston-september-join-them-with-the-early-bird-rate/https://blog.lifesciencenation.com/wp-content/uploads/2023/07/cc-07272023.jpgCC-07272023https://blog.lifesciencenation.com/wp-content/uploads/2023/07/ci-07272023.jpgCI-072720232023-07-27T15:20:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/mastering-the-art-of-partnering-a-roadmap-for-startup-success/2023-07-27T15:18:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/clinials-lsn-educational-workshop-resi-innovators-pitch-challenge-success/https://blog.lifesciencenation.com/wp-content/uploads/2023/07/maree-beare.jpgMaree-Beare2023-07-27T15:18:22+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/hot-investor-mandate-usa-based-vc-invests-in-early-stage-therapeutics-devices-and-diagnostics-companies-globally-seeking-promising-assets-with-strong-ip-in-place/2023-07-27T15:02:57+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/hot-investor-mandate-early-stage-evergreen-fund-seeks-medical-devices-and-research-tools-focusing-on-usa-based-opportunities/2023-07-27T15:02:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/hot-investor-mandate-taiwan-vc-invests-in-innovative-medical-devices-that-address-large-market-opportunities-open-to-all-regulatory-pathways/2023-07-27T15:02:54+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/27/hot-investor-mandate-investment-firm-seeks-pre-clinical-therapeutics-opportunities-with-particular-interest-in-immunology-and-oncology/2023-07-27T15:02:51+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/new-lsn-investor-database-subscription/https://blog.lifesciencenation.com/wp-content/uploads/2023/07/subscribe-now.pngSubscribe Now2023-07-20T18:46:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/lsn-continues-to-build-open-innovation-ecosystem/2023-07-20T16:35:44+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/hot-investor-mandate-corporate-venture-arm-of-manufacturing-company-with-evergreen-fund-invest-in-all-life-science-sectors-including-rd-services/2023-07-20T16:07:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/hot-investor-mandate-usa-based-vc-invests-in-emerging-medical-technology-hcit-and-rd-companies-helping-deliver-quality-healthcare/2023-07-20T16:07:14+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/hot-investor-mandate-early-stage-vc-firm-seeks-new-diagnostics-digital-health-investment-opportunities-in-usa-and-europe/2023-07-20T16:07:12+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/hot-investor-mandate-investment-incubator-firm-invests-2-5m-in-therapeutics-medtech-companies-focusing-on-usa-china-based-opportunities/2023-07-20T16:07:09+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/20/california-life-sciences-interview/https://blog.lifesciencenation.com/wp-content/uploads/2023/07/shikha-sharma.jpegShikha Sharma2023-07-20T15:31:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/life-science-nation-new-product-release-announcement/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/request-a-demo.pngRequest-a-Demohttps://blog.lifesciencenation.com/wp-content/uploads/2023/05/gpc-logo.pngGPC-logo2023-07-20T13:33:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/early-stage-life-science-investors-at-resi/2023-07-13T17:18:22+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/attending-resi-as-a-tech-hub/2023-07-13T17:16:52+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/introducing-resi-sponsor-radyus-research/2023-07-13T16:10:41+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/hot-investor-mandate-vc-focuses-on-pre-seed-to-series-a-investments-in-life-sciences-deeptech-targeting-the-usa-market/2023-07-13T16:09:07+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/hot-investor-mandate-cross-border-vc-invests-up-to-10m-with-strong-interest-in-chronic-disease-management-digital-health-ai-and-more/2023-07-13T16:09:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/hot-investor-mandate-usa-based-firm-seeks-new-investments-in-life-sciences-tools-software-medical-devices-in-pre-seed-to-series-a-rounds/2023-07-13T16:09:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/13/hot-investor-mandate-family-office-looks-for-north-america-based-companies-in-medical-devices-diagnostics-and-first-in-class-therapeutics/2023-07-13T16:08:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/3-part-summer-webinar-series-for-the-early-stage-entrepreneur/https://blog.lifesciencenation.com/wp-content/uploads/2023/07/webinar-banner3.jpgwebinar-banner32023-07-11T19:39:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/free-summer-webinar-series-for-the-early-stage-entrepreneur/https://blog.lifesciencenation.com/wp-content/uploads/2023/06/karen-wp.pngkaren-wphttps://blog.lifesciencenation.com/wp-content/uploads/2023/06/image-1.pngimage-12023-07-11T19:35:36+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/lessons-learned-key-takeaways-from-successful-life-science-entrepreneurs/2023-07-06T17:16:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/hot-investor-mandate-investment-arm-of-leading-conglomerate-invests-across-various-asset-classes-with-strong-interest-in-therapeutics-life-science-tools-diagnostics-and-more/2023-07-06T16:39:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/hot-investor-mandate-investment-firm-actively-seeks-medical-device-diagnostics-technologies-typically-investing-in-series-a-rounds-in-usa-based-companies/2023-07-06T16:37:17+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/hot-investor-mandate-vc-with-usa-and-canada-offices-seeks-therapeutics-medtech-and-consumer-health-technologies-investing-10m-over-company-lifecycle/2023-07-06T16:32:09+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/hot-investor-mandate-usa-based-vc-firm-invests-in-the-earliest-stage-life-science-companies-from-pre-seed-and-beyond-with-strong-interest-in-platform-technologies/2023-07-06T16:30:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/07/06/interview-with-untech/2023-07-06T16:06:46+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/exhibit-at-resi-september/https://blog.lifesciencenation.com/wp-content/uploads/2023/06/image-3.pngimage-3https://blog.lifesciencenation.com/wp-content/uploads/2023/06/image-2-1.pngimage-2-1https://blog.lifesciencenation.com/wp-content/uploads/2023/06/image-2.pngimage-22023-06-29T18:54:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/resi-september-panels/https://blog.lifesciencenation.com/wp-content/uploads/2023/06/image.pngimage2023-06-29T16:02:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/hot-investor-mandate-corporate-vc-firm-of-publicly-listed-pharmaceutical-actively-seeks-platform-therapeutics-companies-in-promising-modalities-investing-up-to-20m/2023-06-29T16:01:05+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/hot-investor-mandate-large-pe-firm-with-us-asia-offices-invests-up-to-20m-in-early-stage-life-science-opportunities-and-up-to-50m-in-growth-stage-opportunities/2023-06-29T15:57:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/hot-investor-mandate-impact-focused-vc-seeks-to-invest-in-therapeutics-devices-diagnostics-companies-typical-check-sizes-in-5-10m-range/2023-06-29T15:53:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/29/hot-investor-mandate-1-newly-founded-vc-fund-invests-up-to-8m-in-global-therapeutics-companies-in-all-modalities-and-disease-areas/2023-06-29T15:49:52+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/resi-boston-june-recap/https://blog.lifesciencenation.com/wp-content/uploads/2023/06/partnering.jpgPartneringhttps://blog.lifesciencenation.com/wp-content/uploads/2023/06/team-photo.jpgTeam-Photohttps://blog.lifesciencenation.com/wp-content/uploads/2023/06/dsc9159.jpg_DSC9159https://blog.lifesciencenation.com/wp-content/uploads/2023/06/resi-boston-2023-september-1100px-w.jpgRESI-Boston-2023-September-1100px-whttps://blog.lifesciencenation.com/wp-content/uploads/2023/06/dsc9285.jpg_DSC9285https://blog.lifesciencenation.com/wp-content/uploads/2023/06/dsc9565.jpg_DSC9565https://blog.lifesciencenation.com/wp-content/uploads/2023/06/dsc9305.jpg_DSC93052023-06-22T16:53:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/unlocking-preclinical-success-learn-from-radyus-researchs-workshop/2023-06-22T16:35:23+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/are-you-out-licensing-take-the-inova-biopharma-survey/https://blog.lifesciencenation.com/wp-content/uploads/2023/06/sarah-issa.jpgSarah-Issahttps://blog.lifesciencenation.com/wp-content/uploads/2021/09/greg_new.jpgGreg_new2023-06-22T16:26:07+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/hot-investor-mandate-usa-based-vc-firm-invests-in-therapeutics-medical-technologies-in-north-america-europe-asia-with-strong-interest-in-oncology-and-rare-diseases/2023-06-22T16:24:57+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/hot-investor-mandate-strategic-corporate-venture-fund-seeks-early-stage-therapeutics-platform-technologies-in-cns-inflammation-and-more/2023-06-22T16:24:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/hot-investor-mandate-venture-fund-formed-by-high-net-worth-individuals-invests-in-novel-devices-diagnostics-and-digital-health-with-focus-in-usa-and-china/2023-06-22T16:24:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/22/hot-investor-mandate-medtech-company-strategically-invests-in-medical-device-companies-particularly-implantable-devices-in-early-and-late-development-stages/2023-06-22T16:24:51+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/15/congratulations-to-the-top-3-ipc-finalists-at-resi-june-boston-2023/https://blog.lifesciencenation.com/wp-content/uploads/2021/05/claire-new.jpgClaire-new2023-06-15T17:49:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/introducing-ipc-judges-at-resi-boston-june/2023-06-01T16:51:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/stellar-content-at-resi-boston-june-5th-2023/2023-06-01T16:19:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/join-lsn-team-at-exciting-life-science-events-next-week/2023-06-01T16:13:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/hot-investor-mandate-europe-based-venture-group-investing-globally-in-therapeutics-open-to-all-modalities-and-indications/2023-06-01T16:13:09+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/hot-investor-mandate-investor-group-looking-to-make-impact-investments-in-companies-in-all-sectors-with-products-including-a-core-technology-component/2023-06-01T16:13:07+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/hot-investor-mandate-us-and-asia-based-private-equity-firm-investing-opportunistically-in-companies-looking-to-enter-the-china-market/2023-06-01T16:13:05+00:00monthlyhttps://blog.lifesciencenation.com/2023/06/01/hot-investor-mandate-east-coast-based-strategic-partner-looking-to-invest-in-license-or-acquire-medical-device-and-digital-health-technologies/2023-06-01T16:13:03+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/25/check-out-the-lineup-at-resi-boston-june-2023/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/gpc-with-tagline.jpgGPC-with-taglinehttps://blog.lifesciencenation.com/wp-content/uploads/2023/05/lifesci-startup-logo.pngLifeSci-Startup-Logohttps://blog.lifesciencenation.com/wp-content/uploads/2023/05/resi-boston-june-2023-program-guide_5192023_v1.jpgRESI-Boston-June-2023-Program-Guide_5192023_v12023-05-30T14:28:36+00:00monthlyhttps://blog.lifesciencenation.com/entrepreneur-elucidated-series/2023-05-26T18:48:56+00:00weekly0.6https://blog.lifesciencenation.com/2023/05/26/interview-with-michelle-chien-national-health-research-institutes/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/130x130.jpg130X130https://blog.lifesciencenation.com/wp-content/uploads/2023/05/24-x120.jpg24-x120https://blog.lifesciencenation.com/wp-content/uploads/2023/05/nhri.jpegNHRI2023-05-26T16:06:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/interview-with-resi-boston-sponsor-burns-levinson/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/shawn-p.-foley.jpgShawn-P.-Foley2023-05-18T16:26:25+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/how-to-improve-your-partnering-metrics-at-resi-boston/2023-05-18T16:20:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/hot-investor-mandate-drug-development-company-with-strategic-investment-arm-interested-in-seed-stage-companies-raising-smaller-rounds-based-in-north-america-europe-and-israel/2023-05-18T15:37:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/hot-investor-mandate-transatlantic-venture-capital-firm-looking-for-new-opportunities-in-diagnostics-medical-devices-and-digital-health-in-us-europe/2023-05-18T15:37:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/hot-investor-mandate-china-based-diagnostics-cvc-looks-for-seed-to-series-b-opportunities-globally-focusing-on-preclinical-to-phase-i-therapeutics-and-in-development-clinical-stage-diagnostics-but-o/2023-05-18T15:37:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/18/hot-investor-mandate-newly-established-us-based-vc-looks-for-early-stage-medtech-and-digital-health-companies-focused-on-us-based-companies-but-open-to-global/2023-05-18T15:37:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/see-whos-exhibiting-at-resi-boston/2023-05-11T16:22:25+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/over-50-companies-pitching-at-resi-boston-june-2023/2023-05-11T16:01:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/partnering-opens-next-week-2/2023-05-11T16:01:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/hot-investor-mandate-global-investment-firm-focusing-on-oncology-therapies-invests-up-to-30m-over-the-companys-lifecycle/2023-05-11T16:00:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/hot-investor-mandate-vc-firm-with-us-asia-offices-seeks-new-investments-in-medical-devices-synthetic-biology-and-digital-health/2023-05-11T16:00:55+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/hot-investor-mandate-investment-arm-of-large-corporation-invests-in-accountable-care-centered-solutions-targeting-the-usa-market/2023-05-11T16:00:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/11/hot-investor-mandate-women-led-vc-seeks-to-invest-in-life-science-companies-addressing-womens-health-prioritizing-europe-based-opportunities/2023-05-11T16:00:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/introducing-the-panelists-at-resi-boston-june/2023-05-04T16:16:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/have-you-heard-about-the-audience-access-pass-aap-at-resi-boston-june/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/aap-june-5-agenda.pngAAP June 5 agendahttps://blog.lifesciencenation.com/wp-content/uploads/2023/05/app-agenda.jpgAPP Agenda2023-05-04T16:11:56+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/global-tech-hub-gathering-in-boston/https://blog.lifesciencenation.com/wp-content/uploads/2023/05/nmsf.pngNMSF2023-05-04T16:11:52+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/hot-investor-mandate-multi-billion-corporation-in-middle-east-actively-seeks-investments-in-therapeutics-diagnostics-and-digital-health/2023-05-04T16:10:37+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/hot-investor-mandate-vc-seeks-early-stage-investment-opportunities-in-biotech-and-digital-health-especially-those-looking-to-expand-into-japan/2023-05-04T16:10:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/hot-investor-mandate-usa-based-venture-firm-invests-up-to-10m-in-pre-clinical-and-clinical-stage-therapeutics-with-novel-approaches/2023-05-04T16:10:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/05/04/hot-investor-mandate-life-science-vc-arm-of-large-corporation-invests-in-all-areas-of-life-sciences-most-interested-in-unmet-need-areas-and-indications/2023-05-04T16:10:32+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/join-350-investors-at-resi-boston-june/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/ci04272023.jpgci042720232023-04-27T15:35:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/first-place-winner-in-the-innovators-pitch-challenge-at-digital-resi-march/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/lyndsey-linke.jpgLyndsey-Linke2023-04-27T15:34:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/life-science-nation-at-biofest-invest/2023-04-27T15:34:13+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/hot-investor-mandate-healthcare-focused-vc-invests-up-to-15m-in-global-life-science-ventures-in-series-a-and-b-financings/2023-04-27T15:30:27+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/hot-investor-mandate-usa-based-investment-firm-seeks-pre-seed-and-seed-opportunities-in-the-intersection-of-healthcare-and-technology/2023-04-27T15:30:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/hot-investor-mandate-vc-firm-in-canada-actively-invests-in-digital-health-open-to-medical-devices-and-diagnostics-with-digital-component-investing-up-to-5m/2023-04-27T15:30:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/27/hot-investor-mandate-venture-firm-with-usa-headquarters-invests-in-technologies-leveraging-biology-technology-and-data-science-mainly-in-seed-to-series-a/2023-04-27T15:30:21+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/the-innovators-pitch-challenge-applications-due-tomorrow/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/ipc-end-banner-2.jpgipc-end-bANNER -2https://blog.lifesciencenation.com/wp-content/uploads/2023/04/2022_0921_resiboston_001s-800x534-1.jpg2022_0921_RESIBoston_001s-800x534https://blog.lifesciencenation.com/wp-content/uploads/2023/04/2022_0921_resiboston_007-800x534-1.jpg2022_0921_RESIBoston_007-800x534https://blog.lifesciencenation.com/wp-content/uploads/2023/04/ipc-end-banner.jpgipc-end-bANNER2023-04-20T16:29:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/how-tech-hubs-can-get-involved-at-resi-boston-june-5-7/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/free_tech-hub-webinar_banner.jpgFREE_TECH-HUB-WEBINAR_Banner2023-04-20T16:21:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/connect-with-300-innovative-life-science-startups-at-resi-boston-conference/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/cs4202023.jpgcs42020232023-04-20T16:17:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/hot-investor-mandate-investment-arm-of-non-profit-organization-focuses-on-life-science-technologies-targeting-blood-diseases-infectious-diseases-and-more/2023-04-20T16:17:04+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/hot-investor-mandate-corporate-vc-invests-in-early-stage-life-science-companies-with-strongest-interests-in-therapeutics-across-all-modalities/2023-04-20T16:17:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/hot-investor-mandate-usa-based-family-office-invests-globally-with-broad-interests-in-promising-life-science-technologies/2023-04-20T16:16:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/20/hot-investor-mandate-china-based-company-seeks-global-investment-and-strategic-partnering-opportunities-with-innovative-ivd-products/2023-04-20T16:16:57+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/exhibiting-at-resi-connect-with-top-life-science-startups/2023-04-13T15:55:07+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/global-roadshow-information-and-preparation/2023-04-13T15:50:03+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/preparing-for-the-innovators-pitch-challenge-ipc-at-resi-boston/https://blog.lifesciencenation.com/wp-content/uploads/2023/04/free_webinar_ipc_apr-18-banner.jpgFREE_WEBINAR_IPC_Apr-18-Banner2023-04-13T15:45:06+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/hot-investor-mandate-asia-based-evergreen-fund-invests-in-early-clinical-stage-biotech-and-medtech-investing-up-to-10m-in-companies-in-sizable-markets/2023-04-13T15:43:20+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/hot-investor-mandate-investment-firm-venture-builder-actively-seeks-therapeutics-opportunities-investing-from-as-early-as-discovery-phase/2023-04-13T15:43:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/hot-investor-mandate-usa-based-vcs-inaugural-fund-invests-in-therapeutics-diagnostics-and-life-science-tools-can-also-invest-in-likeminded-funds/2023-04-13T15:43:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/13/hot-investor-mandate-investment-firm-supports-life-science-technologies-through-funding-and-company-formation-focusing-on-north-america-based-companies/2023-04-13T15:43:13+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/the-right-place-and-meet-with-real-investors-heres-why-startups-attend-resi/2023-04-06T17:31:39+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/rx-bandz-finds-great-success-at-resi/2023-04-06T17:21:11+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/global-target-list-key-to-a-successful-fundraise/2023-04-06T16:51:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/hot-investor-mandate-corporate-vc-firm-invests-up-to-10m-in-tech-enabled-services-and-digital-health-companies-based-in-the-usa/2023-04-06T16:47:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/hot-investor-mandate-investment-firm-supports-next-generation-companies-in-cell-gene-therapy-addressing-cns-oncology-and-other-high-unmet-need-indications/2023-04-06T16:47:51+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/hot-investor-mandate-western-europe-firm-involved-in-company-creation-investments-in-devices-diagnostics-technologies-addressing-sizable-markets-investing-up-to-e7m/2023-04-06T16:47:49+00:00monthlyhttps://blog.lifesciencenation.com/2023/04/06/hot-investor-mandate-usa-based-vc-invests-up-to-10m-over-companys-lifecycle-seeking-medtech-and-digital-health-technologies/2023-04-06T16:47:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/lsn-entrepreneurial-education-program-at-biomedsa/2023-03-30T17:05:59+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/resi-boston-june-investor-panel-line-up/https://blog.lifesciencenation.com/wp-content/uploads/2023/03/resi-june-investor-panel-agenda.jpgRESI-June-Investor-Panel-Agenda2023-03-30T17:03:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/lsn-10-years-connecting-players-in-the-life-sciences/2023-03-30T17:03:47+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/hot-investor-mandate-family-office-invests-in-clinical-stage-devices-diagnostics-companies-interested-in-expanding-into-the-canada-market/2023-03-30T17:02:44+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/hot-investor-mandate-cross-border-fund-seeks-global-opportunities-in-medtech-most-interested-in-cvd-chronic-diseases-and-more/2023-03-30T17:02:38+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/hot-investor-mandate-usa-investment-firm-actively-seeks-novel-medical-devices-smart-manufacturing-technologies-with-strong-ip/2023-03-30T17:02:36+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/30/hot-investor-mandate-china-based-vc-firm-with-an-inaugural-usd-fund-seeks-investment-opportunities-in-therapeutics-diagnostics-addressing-unmet-clinical-need/2023-03-30T17:02:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/22/congratulations-to-the-ipc-winners-next-up-resi-boston-june-5-7/2023-03-22T20:18:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/digital-resi-march-a-tailor-made-conference-for-early-stage-life-science-fundraising-startups/https://blog.lifesciencenation.com/wp-content/uploads/2023/03/resi-march-agenda-03092023.jpgRESI-March-Agenda-030920232023-03-09T19:29:41+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/audience-access-pass-a-runway-for-your-fundraising-journey/https://blog.lifesciencenation.com/wp-content/uploads/2023/03/aap_march.jpgAAP_March2023-03-09T18:15:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/innovators-pitch-challenge-judges-at-digital-resi-march/2023-03-09T17:30:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/hot-investor-mandate-multi-billion-aum-investment-firm-seeks-to-invest-in-all-areas-of-life-sciences-healthcare-across-the-globe/2023-03-09T17:28:38+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/hot-investor-mandate-funding-arm-of-usa-based-health-system-invests-in-digital-health-solutions-with-strong-strategic-alignment/2023-03-09T17:28:35+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/hot-investor-mandate-usa-based-vc-invests-up-to-20m-in-transformational-technologies-in-therapeutics-diagnostics-and-digital-health/2023-03-09T17:28:34+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/09/hot-investor-mandate-vc-with-us-europe-offices-seeks-early-stage-life-science-companies-in-all-sectors-with-strong-interest-in-platform-technologies/2023-03-09T17:28:33+00:00monthlyhttps://blog.lifesciencenation.com/next-phase-podcast/2023-03-03T19:03:40+00:00weekly0.6https://blog.lifesciencenation.com/2023/03/02/with-500-attendees-34-entrepreneurs-were-selected-to-pitch-in-the-innovators-pitch-challenge/2023-03-02T19:26:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/why-early-entrepreneurs-should-be-at-digital-resi-in-march/2023-03-02T16:43:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/put-your-best-foot-forward-and-check-out-the-resi-survival-guide/2023-03-02T16:40:44+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/hot-investor-mandate-vc-with-usa-europe-offices-invests-up-to-e15m-in-therapeutics-and-medical-device-companies-open-to-all-types-of-technologies-and-indications/2023-03-02T16:39:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/hot-investor-mandate-usa-based-venture-firm-seeks-investment-opportunities-in-digital-health-and-data-driven-medical-devices-primarily-in-north-america/2023-03-02T16:39:43+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/hot-investor-mandate-vc-firm-backed-by-a-family-trust-invests-in-all-life-science-technologies-related-to-cardiovascular-and-neurovascular-disease-globally/2023-03-02T16:39:41+00:00monthlyhttps://blog.lifesciencenation.com/2023/03/02/hot-investor-mandate-asia-based-investment-firm-with-1b-aum-invests-around-5m-and-more-into-early-clinical-stage-projects-with-strong-interests-in-therapeutics-and-digital-therapeutics/2023-03-02T16:39:40+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/life-science-nation-x-brisbane-economic-development-agency-beda-equals-resi-success/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/microsoftteams-image-5.jpgMicrosoftTeams-image (5)https://blog.lifesciencenation.com/wp-content/uploads/2023/02/miriam-kent.jpgMiriam-Kent2023-03-01T15:35:12+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/introducing-digital-resi-march-panelists/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/momo.jpgMomo2023-02-23T17:57:01+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/hot-investor-mandate-family-owned-company-with-global-offices-manages-venture-fund-investing-in-promising-projects-in-anti-aging-and-neuroscience-related-indications/2023-02-23T17:55:51+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/hot-investor-mandate-usa-based-fund-actively-seeks-therapeutics-medtech-and-digital-health-investing-up-to-20m-in-series-a-financings-and-beyond/2023-02-23T17:55:50+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/hot-investor-mandate-europe-based-investment-firm-seeks-opportunities-in-healthtech-and-digital-health-investing-up-to-10m-over-the-companys-life-cycle/2023-02-23T17:55:48+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/23/hot-investor-mandate-family-office-invests-in-seed-to-early-venture-stage-medical-device-digital-health-companies-with-interests-in-cns-ophthalmology-chronic-diseases-and-more/2023-02-23T17:55:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/how-to-improve-your-partnering-metrics-at-resi/2023-02-16T18:58:33+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/since-fundraising-is-a-numbers-game-lsn-is-bundling-digital-resi-march-and-face2face-resi-june-boston/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/resi-boston-2023-june-1100px.jpgRESI-Boston-2023-June-1100pxhttps://blog.lifesciencenation.com/wp-content/uploads/2023/02/resi-boston-2023-june-1100px-border.jpgRESI-Boston-2023-June-1100px-border2023-02-16T16:13:53+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/attitude-and-execution-combine-to-be-a-self-fulfilling-prophecy/2023-02-16T16:10:58+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/hot-investor-mandate-cvc-arm-of-global-pharma-invests-up-to-15m-over-the-companys-lifecycle-seeking-therapeutics-digital-health-opportunities/2023-02-16T16:09:26+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/hot-investor-mandate-western-europe-based-vc-seeks-therapeutics-companies-in-pre-clinical-and-early-clinical-stage-also-active-in-company-building/2023-02-16T16:09:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/hot-investor-mandate-usa-based-investment-firm-provides-funding-to-global-opportunities-in-the-intersection-of-science-technology-data-science-etc/2023-02-16T16:09:22+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/16/hot-investor-mandate-private-investment-firm-invests-up-to-10m-in-usa-or-europe-based-companies-across-all-life-science-sectors-typically-investing-at-seed-stage/2023-02-16T16:09:21+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/early-bird-ends-tomorrow-meet-with-these-investors-at-resi-march/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/ci-02092023.jpgCI-020920232023-02-09T16:43:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/entrepreneurial-education-at-digital-resi-march/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/resi-march-agenda-n.jpgRESI-March-Agenda-n2023-02-09T16:13:24+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/early-stage-fundraising-101-free-webinars/2023-02-09T16:13:19+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/bridging-the-gap-between-academia-and-industry-2/2023-02-09T16:13:16+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/hot-investor-mandate-large-holding-company-with-multiple-investment-vehicles-seeks-to-invest-in-software-based-digital-health-companies-targeting-the-usa-market/2023-02-09T16:12:13+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/hot-investor-mandate-vc-growth-equity-firm-actively-seeks-devices-diagnostics-and-digital-health-investing-up-to-30m-over-the-companys-life-cycle/2023-02-09T16:12:11+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/hot-investor-mandate-western-europe-based-investment-firm-seeks-global-investments-in-therapeutics-and-diagnostics-focusing-on-age-related-diseases/2023-02-09T16:12:09+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/09/hot-investor-mandate-investment-firm-with-global-offices-supports-life-science-companies-on-funding-clinical-trials-most-focused-on-therapeutics-but-open-to-other-sectors/2023-02-09T16:12:08+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/02/i-asked-an-ai-robot-to-tell-me-about-entrepreneurial-storytelling-i-am-not-kidding/2023-02-02T17:23:18+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/02/new-global-partnering-campaign-roadshow-preparation-entrepreneurial-education-series/2023-02-02T16:07:45+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/02/digital-resi-march-panel-line-up/https://blog.lifesciencenation.com/wp-content/uploads/2023/02/digital-resi-march-panel-agenda.jpgDigital-RESI-March-Panel-Agendahttps://blog.lifesciencenation.com/wp-content/uploads/2023/02/love-headshot.jpgLove-headshot2023-02-02T16:06:02+00:00monthlyhttps://blog.lifesciencenation.com/2023/02/02/hot-investor-mandate-global-life-sciences-solutions-provider-seeks-to-partner-with-and-invest-in-early-stage-companies-developing-diagnostics-life-science-research-tools/2023-02-02T16:04:37+00:00monthlyhttps://blog.lifesciencenation.comdaily1.02026-03-31T16:14:24+00:00